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Zusammenfassung
Das bgl-Operon von Escherichia coli wird auf mehreren Ebenen reguliert. Das
'Silencing' wird zusätzlich zur bekannten Repression/Aktivierung des Promotors
durch die Limitierung von BglG bei niedrigen Expressionsraten und die Regulation
der bglG-mRNA-Stabilität durch H-NS und andere pleiotrope Faktoren  gesteuert.
Sequenzen, die 'Upstream' und 'Downstream' des Promotors kartieren, sind für
das Silencing essentiell. Die Funktion des Downstream Silencer war bisher ungeklärt.
Ein neuer post-transkriptioneller Mechanismus der Regulation des bgl Operons wurde
aufgedeckt. Entscheidend dabei ist die Regulation der bglG-mRNA-Stabilität. So
reprimiert das H-NS Protein die Expression über den 'downstream silencer' 14-fach,
in dem es die bglG-mRNA Stabilität vermindert. Diese Repression ist höher als die
Repression des bgl-Promotors (und damit des Operons) durch Bindung von H-NS an
die Upstream-Silencer-DNA-Sequenz. Die Stabilität der 'Leader'-RNA wird nicht
durch H-NS verändert.
Die von den drei Genen pgi, lon und hfq kodierten Proteine, wurden als
Faktoren identifiziert, die für die Expression des (durch De-Repression des
Promotors) aktivierten bgl-Operons notwendig sind. Weitere Analysen zeigten, dass
Hfq unabhängig vom Promotor und der Termination/Antitermination im Leader wirkt.
Für den positiven Effekt von Hfq ist die für bglG kodierende Region notwendig.
Wahrscheinlich wird die bglG-mRNA Stabilität durch Hfq, Pgi und translatierende
Ribosomen erhöht.
Das Protein BglG bewirkt die transkriptionelle Antitermination im Leader des
Operon. Es wurde gezeigt, dass die zelluläre Konzentration von BglG bei niedrigen
Transkriptionsraten limitierend ist. Dies hat zur Folge, dass die Antitermination (und
damit Expression des Operons) erst ab einer Schwellenwert-Konzentration von BglG
erfolgt, wodurch der Grad des Silencings und der Aktivierung des Operons signifikant
verstärkt wird.
Früheren Arbeiten ließen vermuten, dass zusätzlich zu H-NS andere Faktoren
für die Ausbildung eines Nukleoproteinkomplexes notwendig sind, durch den der
Promotor reprimiert wird. In in-vitro-Bindestudien wurde H-NS als einziges Protein
identifiziert, das an den Upstream Silencer und/oder die Promotorregion bindet. Mit
dem hier charakterisierten Mechanismus des bgl-Silencings durch die Downstream-
Silencer-Sequenz, lassen sich die früheren Ergebnisse und deren Widersprüche
erklären.
III
Summary
The Escherichia coli bgl operon was shown, in the present work, to be
regulated at multiple levels viz. repression/activation of the bgl promoter,
amplification of bgl silencing/activation by limitation of antiterminator BglG at low
expression levels and regulation of the bglG mRNA stability by H-NS and other
pleiotropic factors.
Silencer sequences upstream and downstream of the bgl promoter were
previously shown to be essential for silencing, but the role of the downstream silencer
was not understood. A new post-transcriptional mechanism of the bgl operon
regulation via the downstream silencer was discovered. Regulation of the bglG
mRNA stability emerged as a prominent theme. The H-NS protein was found to
downregulate the bgl expression at the downstream silencer sequence by reducing the
bglG mRNA stability. This downregulation was up to 14 fold and was found to be
more than the H-NS mediated downregulation of the bgl promoter, and thus the
operon, via the upstream silencer. H-NS was found to decrease the half life of the
bglG mRNA whereas it did not affect the stability of the bgl leader mRNA.
Proteins encoded by three genes, namely pgi, lon and hfq were found to be
required for expression of the bgl operon when the promoter was de-repressed.
Further analysis showed that the role of Hfq protein is independent of the bgl
promoter regulation and termination/antitermination. The bglG sequence, which is
part of the downstream silencer, was found to be essential for the positive regulatory
effect of Hfq. The bgl mRNA stability is presumably positively regulated by Hfq, Pgi
and the translating ribosomes.
In the promoter downstream region, transcriptional termination is prevented
by the antiterminator protein BglG. It was found that cellular levels of BglG are
limiting and the requirement for a BglG threshold could amplify the silencing or
activation of the bgl operon.
Unknown Cellular factors in addition to H-NS were previously postulated to
be essential to form a nucleoprotein complex at the silencers flanking the bgl
promoter. Only H-NS was found to bind, in vitro, to the upstream silencer and
promoter region of the bgl operon. The mechanism by which the downstream
sequences contribute to bgl silencing discovered in the present work could explain the
previously proposed requirement of additional cellular factors for bgl silencing.
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II. Introduction
 The paradigm of gene regulation in prokaryotes is specific regulators like the
Lac repressor regulating expression of the lac operon at the transcriptional level.
However, increasing evidence points to regulation of a large numbers of prokaryotic
genes by pleiotropic gene regulators at various levels of the gene expression including
transcription, RNA modification/stability, translation and protein stability. In
Escherichia coli, nucleoid-associated proteins like the histone-like nucleoid
structuring protein (H-NS) have been shown to affect the expression of approximately
5% of the total number of proteins (Hommais et al., 2001). The mechanisms by which
H-NS and other pleiotropic proteins regulate gene expression may well be diverse and
are not completely understood. One of the operons which is directly and indirectly
regulated by a multitude of pleiotropic regulators, including H-NS and others, is the
bgl operon.
1. The cryptic bgl operon of Escherichia coli.
In E. coli, the utilization of b-glucosidic sugars like salicin, arbutin and esculin
requires expression of the cryptic bgl (b-glucoside utilization) operon (figure 1a, b).
Cryptic or silent genes have been defined as genes that are not expressed during the
normal life cycle of an organism (Hall et al., 1983). However, their expression can be
caused by mutations that abolish the silent state. The bgl operon was first discovered
by isolating spontaneous mutants of E. coli K12 which were capable of metabolizing
b-glucosides (Schaefler and Maas, 1967). The bgl operon (schematically shown in
figure 1a) contains six genes (bglG, F, B, H, I and K ) which are expressed from a
single promoter. Of these genes, the first three genes are sufficient for utilization of
the b-glucosides (Prasad and Schaefler, 1974; Mahadevan et al., 1987; Schnetz et al.,
1987). Two rho-independent transcriptional terminators, bglt1 and t2, flank the first
gene bglG encoding the antiterminator BglG (Mahadevan and Wright, 1987; Schnetz
et al., 1987; Schnetz and Rak, 1988). The BglG activity is regulated by the catabolic
state of the cell as well as presence of b-glucosides and other sugars as discussed
below. When active, the BglG protein causes antitermination at the terminators t1 and
t2 and allows transcriptional readthrough (Houman et al., 1990; Aymerich and
Steinmetz, 1992). The second gene bglF codes for a membrane transport protein
EnzymeIIBgl and specifically transports b-glucosides across the cell membrane and
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negatively regulates the BglG activity (Schnetz et al., 1987; Saier et al., 1988). The
third gene bglB codes for the enzyme phospho-b-glucosidase which catalyzes the first
hydrolysis step of b-glucoside utilization (Prasad and Schaefler, 1974; Mahadevan et
al., 1987; Schnetz et al., 1987).
2. Silencing and activation of the bgl operon.
The bgl promoter consists of the –10 and –35 conserved motifs and a
catabolite regulator protein (CRP) binding site upstream of the –35 box (Reynolds et
al., 1981; Reynolds et al., 1986). The wt bgl promoter is silent i.e. there is no
significant transcription and the cells are phenotypically Bgl-. After further incubation
on indicator plates containing salicin, spontaneous mutants (papillae) arise which are
phenotypically Bgl+. These spontaneous mutants are integrations of insertion elements
(eg IS1 and IS5) in the AT-rich region upstream of the promoter, integrations in the
region downstream of the promoter, deletions of promoter upstream regions, point
mutations like mutation C234 (a single bp change from C to T at position –66 relative
to transcription start) which improves the CRP binding site and causes CRP binding
with higher affinity (figure 2) (Reynolds et al., 1986; Schnetz and Rak, 1988; Lopilato
and Wright, 1990; Schnetz and Rak, 1992; Schnetz, 1995; Singh et al., 1995).
Figure 1. The E. coli bgl operon. a) The operon contains six genes of which the first three are sufficient
for b-glucoside utilization (Prasad and Schaefler, 1974; Mahadevan et al., 1987; Schnetz et al., 1987).
Two rho-independent transcriptional terminators, bglt1 and t2 are also shown. b) Chemical structures of
b-glucosides arbutin, salicin and esculin (Rimpler, 1990).
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There are also trans activating mutations eg in the hns gene (Defez and de
Felice, 1981; Higgins et al., 1988), which encodes the histone like nucleoid
structuring protein H-NS (see below), in the gyrase genes gyrA and gyrB (minor
effect) (DiNardo et al., 1982), mutations causing overexpression of the bglJ gene
which codes for a protein with homology to the UhpA-LuxR family of transcriptional
activators (Giel et al., 1996) and mutations causing overexpression of the leuO gene
which encodes a putative LysR-like DNA-binding protein (Ueguchi et al., 1998).
Flanking the bgl promoter are two silencer sequences. The AT-rich upstream
silencer is located 5' to the CRP binding site and the downstream silencer
encompasses the bgl leader and the bglG sequence. It has been shown that both the
upstream and the downstream silencer sequences are required for bgl silencing
(Schnetz, 1995). The operon is active in the absence of either of the silencers.
Similarly other active promoters, eg the lac promoter, are silenced when placed in
context of the two silencers (Schnetz, 1995). Thus, it is the presence of the bgl
promoter in context of these two silencer sequences which makes it cryptic. It was
proposed that a silencing nucleoprotein complex forms at these silencers (Schnetz,
1995; Caramel and Schnetz, 1998). H-NS is an essential component of the complex.
Formation of the repressing nucleoprotein complex presumably prevents access to the
promoter by CRP and RNA polymerase (figure 2). Protein FIS (factor for inversion
Figure 2. Silencing and activation of the bgl promoter. c) The wt bgl promoter (Pbgl) is silenced in
context of the upstream and downstream silencer sequences (gray bars). The CRP binding site (CRP),
terminator t1 and the first gene bglG are shown. According to the nucleoprotein repressor complex model
(Schnetz, 1995; Caramel and Schnetz, 1998), H-NS (black ovals) binds the upstream AT-rich sequence
and presumably promotes the formation of a silencing nucleoprotein complex (white ovals) involving Fis
(black quadrangles) and possibly other unknown cellular factors. Spontaneous mutations in cis which can
relieve silencing include insertions (IS1 and IS5) in the silencers, deletions of the silencers (D), or point
mutations like CRP binding site mutation C234 which improves the CRP binding site. Numbers indicate
nucleotide position relative to transcription start (Reynolds et al., 1986; Lopilato and Wright, 1990;
Schnetz and Rak, 1992; Schnetz, 1995; Singh et al., 1995).
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stimulation, see below) may form a part of this complex (Caramel and Schnetz, 2000).
Furthermore, it was reported that in vitro, the wt bgl promoter is active (Schnetz and
Wang, 1996). It could be, like its activated alleles (the improved CRP binding site
mutant and the allele activated by partial deletion of the upstream silencer),
transcribed in single round transcription assays by RNA polymerase from negatively
supercoiled templates. In this case the transcription was CRP independent. When
relaxed DNA templates were used, in vitro transcription became CRP-cAMP
dependent but the levels of transcription from the wt and the active promoters were
similar. H-NS rendered both the wt and the activated promoters CRP-dependent.
Further addition of crude cell extracts was necessary for specific repression of the wt
bgl promoter in the presence of CRP-cAMP. The repression of the improved CRP
binding site promoter allele by crude cell extracts was reversible by addition of
CRP-cAMP. Thus, it was postulated that H-NS forms a essential part of the repressing
nucleoprotein complex but cellular factors in addition to H-NS are required for
formation of the complex.
3. Regulation of the BglG activity.
The key element in the substrate-specific regulation is the antiterminator
protein BglG encoded by the first gene of the operon (Prasad and Schaefler, 1974;
Mahadevan and Wright, 1987; Mahadevan et al., 1987; Schnetz et al., 1987; Schnetz
and Rak, 1988). BglG mediates specific antitermination at two rho-independent
terminators, located in the leader of the operon and in the inter-cistronic region
between the bglG and the bglF genes, respectively (Mahadevan and Wright, 1987;
Schnetz et al., 1987; Schnetz and Rak, 1988). Active BglG dimer binds to the mRNA
at a BglG-binding motif which forms alternatively to and overlapping with the
transcriptional terminator t1 loop and prevents formation of the latter (Houman et al.,
1990; Aymerich and Steinmetz, 1992; Amster-Choder and Wright, 1992). Thus, BglG
binding mediated prevention of the terminator loop formation allows transcriptional
readthrough or antitermination (Houman et al., 1990; Aymerich and Steinmetz, 1992)
(figure 3). BglG also binds to a similar target sequence in the second terminator bgl t2
region (Amster-Choder and Wright, 1993). BglG activity is controlled by reversible
phosphorylation both negatively and positively in response to the availability of the
specific substrate and the catabolic state of the cell, respectively. In the absence of
b-glucosides, the sugar-specific permease enzymeIIBgl, which is encoded by the
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second gene bglF of the operon, catalyzes phosphorylation of BglG which
presumably prevents its dimerization to the active form (Schnetz and Rak, 1988;
Amster-Choder et al., 1989; Amster-Choder and Wright, 1990; Schnetz and Rak,
1990; Amster-Choder and Wright, 1992). In the presence of b-glucosides and absence
of other PTS-carbohydrates, BglG is phosphorylated at a second site and thereby
activated by HPr (Görke and Rak, 1999). HPr is a main component of the
phospho-enol-pyruvate-dependent phosphotransfer system (PTS) that mediates and
controls the uptake and fermentation of carbohydrates (figure 3) (Postma et al., 1993;
Saier and Reizer, 1994).
Figure 3. b-glucoside specific regulation of the bgl operon. Left, in the absence of b-glucosides, the
transport protein IIBgl is phosphorylated (~P) by Hpr, a component of the PTS system. This phosphate is
transferred to cause phosphorylation of the BglG protein (gray semicircles) and thus inactivating the
latter. Hpr also phosphorylates BglG directly. Center, in the presence of b-glucosides, the transport
protein IIBgl transfers the phosphate to the incoming b-glucosides and not to BglG. This form of BglG,
phosphorylated only by Hpr is active, it dimerizes and binds to the BglG binding mRNA motif
overlapping with the t1 loop and causes antitermination. Right, in the presence of excess of
b-glucosides or other PTS sugars, all the phosphate is drained away from Hpr, and BglG becomes
totally unphosphorylated and inactive (Mahadevan and Wright, 1987; Schnetz et al., 1987; Schnetz and
Rak, 1988; Amster-Choder et al., 1989; Schnetz and Rak, 1990; Amster-Choder and Wright, 1992;
Görke and Rak, 1999). Figure outline modified according to (Görke and Rak, 1999)
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4. Factors involved in regulation of the bgl operon.
Besides the positive regulator BglG, no specific regulators of the bgl operon
are known. Proteins involved in regulation of the bgl operon which were known
previously or were discovered during the course of this work are briefly described
below. All these proteins are non-specific or pleiotropic regulators of E. coli gene
expression.
H-NS: This is a small (15.4kDa) histone like protein involved in structuring of the E.
coli chromsome´s higher order structure called the nucleoid (Drlica and Rouvière-
Yaniv, 1987; Tupper et al., 1994; Williams and Rimsky, 1997; Dorman et al., 1999).
H-NS can bind non-specifically to DNA with a preference to AT-rich and curved
sequences (Bracco et al., 1989; Yamada et al., 1991; Owen-Hughes et al., 1992;
Tupper et al., 1994; Zuber et al., 1994).  H-NS binding has been shown to compact
DNA (Spassky et al., 1984; Spurio et al., 1992), change DNA topology (Higgins et
al., 1988; Owen-Hughes et al., 1992; Mojica and Higgins, 1997) and to constrain
negative DNA supercoils in vitro (Tupper et al., 1994). Besides its structural function,
it is known to be involved in regulation of various genes and operons besides the bgl
operon, eg CFA/I fimbrial operon (Jordi et al., 1992), proU which encodes an
osmo-protective glycine-betaine system (Higgins et al., 1988; Lucht et al., 1994;
Fletcher and Csonka, 1995) and the rRNA operon rrnB (Tippner et al., 1994;
Afflerbach et al., 1998).  H-NS regulates the hns gene itself (Dersch et al., 1993;
Ueguchi et al., 1993; Falconi et al., 1993). In most cases, H-NS inhibits the
transcription of its target genes by either changes in the DNA topology and/or by
preventing RNA polymerase or transcriptional activators from accessing the DNA
(Higgins et al., 1988). H-NS regulated genes eg those encoding virulence factors,
pathogenic determinants, etc. often respond to environmental signals such as
temperature, pH, osmolarity and Oxygen availability (Atlung and Ingmer, 1997).
H-NS mediated regulation of the bgl operon may also be subject to environmental
perturbations. It was shown (Khan and Isaacson, 1998) that the bgl operon may be
activated in pathogenic E. coli in vivo (inside the host) where specifically activating
environmental conditions may exist.
Fis: Factor for inversion stimulation (Fis) was discovered as a protein that stimulates
site specific DNA inversion (Johnson and Simon, 1985; Kahmann et al., 1985; Huber
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et al., 1985). It is a homodimer of 11.2 kDa subunits. It can bind to and bend DNA
(Finkel and Johnson, 1992). Fis expression is growth rate regulated and dramatically
increases for a short period in the early exponential growth phase in a rich medium
(Ball et al., 1992; Nilsson et al., 1992; Ninnemann et al., 1992). Fis was shown to
bind in vitro to the bgl upstream silencer and promoter regions, it could compete in
vitro with CRP for binding to the wt bgl promoter but not with RNA polymerase. It
was also shown that Fis can prevent in vitro transcription from a wt bgl promoter
(Caramel and Schnetz, 2000). Fis is known to be involved in various other processes
like regulation of DNA replication at oriC (Gille et al., 1991; Filutowicz et al., 1992),
phage l excision (Ball and Johnson, 1991), and modulation of DNA topology
(Schneider et al., 1997). Fis stimulates transcription of stable RNA promoters
(Nilsson et al., 1990; Ross et al., 1990) and regulates a set of RpoS dependent genes
including aldB, proP, glnQ, mglA, xylF and sdhA (Xu and Johnson, 1995a; Xu and
Johnson, 1995b). Transcription of the fis gene itself is subject to auto-regulation
(Ninnemann et al., 1992). Fis regulates the crp gene encoding the catabolite regulator
protein (González-Gil et al., 1998), hns gene (Falconi et al., 1996) and the hupA and
hupB genes encoding HU (Claret and Rouvière-Yaniv, 1996).
StpA: It is  67% similar to the H-NS protein (Johansson and Uhlin, 1999) and can
functionally substitute H-NS in several cases, although it displays unique properties of
its own (Zhang and Belfort, 1992; Zhang et al., 1996; Sonden and Uhlin, 1996). StpA
has RNA chaperone activity (Zhang et al., 1995) and it can also bind DNA
(Sonnenfield et al., 2001). Expression of StpA is negatively regulated by H-NS but
stimulated by the leucine-responsive protein Lrp (Sonden and Uhlin, 1996). The StpA
and H-NS proteins can form heteromers (Williams et al., 1996). In one study where
the H-NS protein was truncated for its C-terminal DNA binding domain, it was found
that StpA is required for bgl repression and was proposed to act as an adapter for
binding of the truncated H-NS to DNA (Free et al., 1998), while in another analysis
RpoS has been identified to be required for silencing by the truncated H-NS protein
and the involvement of StpA was not confirmed (Ohta et al., 1999). StpA has also
been reported to have a negative effect on bgl expression in a wt hns background
(Free et al., 1998). It was shown that StpA is susceptible to proteolysis by the Lon
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protease in the absence of H-NS but was stable in the presence of H-NS. (Johansson
and Uhlin, 1999; Johansson et al., 2001).
Lon: It is a ATP-dependent protease and Lon monomer consists of an ATPase
domain and a proteolytic domain. It forms ring-like multiple layered polymers which
are the active forms of the protein (Gottesman, 1996; Wickner et al., 1999). Lon
expression is upregulated on heat shock and starvation stress where it is involved in
the proteolysis of inactivated or misfolded proteins (Baker et al., 1984; Goff et al.,
1984; Phillips et al., 1984; Kuroda et al., 2001). Lon specifically degrades proteins
like cell division inhibitor SulA (Goff et al., 1984), the F-plasmid dependent
protective protein CcdA (Van Melderen et al., 1994), the l phage life cycle regulatory
proteins N and Xis (Maurizi, 1987; Leffers and Gottesman, 1998), the DNA damage
checkpoint effector, UmuD protein (Diez-Gonzalez et al., 1998) and RcsA which
regulates capsular polysaccharide synthesis (Stout et al., 1991). As described above,
Lon degrades StpA protein in the absence of H-NS (Johansson and Uhlin, 1999). Lon
has been reported to bind DNA specifically (Fu et al., 1997).
Hfq: Host factor for Qb  phage replication is a abundant 15kDa protein and is required
for replication of the RNA genome of the Qb  (August and Shapiro, 1968; Franze de
Fernandez et al., 1968; Franze de Fernandez et al., 1972). Hfq functions by
destabilizing an RNA secondary structure on the 3' end of the positive strand of Qb
RNA. In addition Hfq binds poly(A) RNA (Carmichael, 1975; Senear and Steitz,
1976) and oxyS RNA (Zhang et al., 1998). Several mRNAs in E. coli are targeted for
degradation by Hfq, possibly by increasing polyadenylation (Hajnsdorf and Regnier,
2000) or by interfering with the ribosome binding (Vytvytska et al., 2000). Efficient
translation of RpoS in E. coli (Muffler et al., 1996) and Salmonella typhimurium
(Brown and Elliott, 1996) requires Hfq. The mRNAs of E. coli genes ompA, miaA,
mutS and hfq are destabilized by Hfq (Tsui et al., 1997; Vytvytska et al., 1998). The
Hfq protein can be copurified with H-NS and overexpression or mutation of Hfq can
mask some hns phenotypes (Shi and Bennett, 1994).
RpoS: It is the alternative sigma factor of E. coli RNA polymerase and is required for
transcription of many genes expressed during the onset of stationary growth phase
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(Loewen and Hengge-Aronis, 1994). RpoS is also required for expression of genes
involved in adaptation to stresses like starvation, high osmolarity, heat shock,
peroxide stress, and UV exposure (Hengge-Aronis, 1993). RpoS expression is
regulated at multiple levels and Hfq is required for translation of the rpoS mRNA. As
described before, RpoS was reported to be necessary for silencing of the bgl operon
by truncated H-NS.
5. Open questions and possible approaches.
What additional factors besides H-NS are required for formation of the
proposed silencing nucleoprotein complex?
They could presumably bind to the silencer/bgl DNA sequences and thus could be
purified based on this presumed bgl DNA binding property and identified. Another
possible approach to identify factors involved in bgl silencing was a genetic one.
Random mutagenesis screens could be performed and mutants defective in bgl
silencing i.e. those in which the wt bgl operon is expressed could be identified using a
suitable selection strategy. Also a reverse screen could be carried out in which
mutations causing downregulation of an active bgl operon could be identified.
It has been shown that H-NS can specifically bind to the upstream bgl silencer
DNA (Wahle and Schnetz, unpublished results). This supports the role of the
upstream silencer in formation of the repressor complex. However, H-NS can not
specifically bind to the downstream silencer (Wahle and Schnetz, unpublished
results). What is then the mechanism of silencing by the downstream silencer?
It is possible that H-NS binds specifically to the upstream silencer along with other
unknown factors and this repressor complex may "spread over" on to the downstream
regions. However other mechanisms of downstream silencer mediated silencing are
possible.
Regulation of the bgl operon expression was usually studied using plasmidic
reporter gene constructs for quantitative analysis. It is possible that the bgl operon
regulation on multicopy plasmids is different than that on the chromosome (natural
situation) eg due to limiting levels of positive or negative regulators.
In order to assess this possibility expression on plasmidic and chromosomal systems
could be compared.
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6. Aim of the thesis
The aim of this thesis was to study following aspects of the Escherichia coli
bgl operon regulation
- Identification of cellular factors involved in the bgl operon regulation in
addition to H-NS and to study their role.
- Analysis of the role of the silencer sequence downstream of the bgl
promoter.
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III. Results
1. Biochemical characterisation of proteins binding to the upstream silencer
region of the bgl operon.
According to the silencing nucleoprotein complex model (Schnetz, 1995;
Schnetz and Wang, 1996; Caramel and Schnetz, 1998) the H-NS protein is an
essential component of the repressing complex. However in vitro data indicated that
H-NS is not sufficient to repress the wt bgl promoter (Schnetz and Wang, 1996).
Additional cellular components were required to specifically prevent transcription
from the wt bgl promoter in vitro (Schnetz, 1995). To characterize E. coli proteins
which in addition to H-NS may bind to the upstream bgl silencer a biochemical
approach was taken.
The principle of the method based on DNA affinity chromatography is shown in
figure 4. Biotinylated DNA fragment including the upstream silencer region
Figure 4: Principle of DNA affinity chromatography
                                        Results                                     12
corresponding to the bgl operon nucleotide positions –191 to +79 (with the
transcriptional start site as +1) was used as a "bait" for protein binding. As a negative
control a similarly sized biotinylated DNA fragment corresponding to the lacZ gene
was used (figure 5). These fragments were then allowed to bind to Streptavidin coated
magnetic beads. After washing off unbound DNA, cell extracts made from wt (S541 =
Dbgl-AC11 (gpt-lac)+ ) or hns cells (S102 = hns::ApR) were added. In another
experiment the cell extracts used were pre-purified and concentrated for DNA-binding
proteins, by binding to phosphocellulose and washing off the non-binding proteins.
After allowing the cellular proteins to bind to the DNA attached to the magnetic
beads, unbound and nonspecifically bound proteins were washed off. The specifically
bound proteins were subsequently eluted using a high salt (700mM KCl) containing
buffer (see Materials and Methods for details). These eluted proteins were then
precipitated with trichloroacetic acid, resuspended and separated on SDS-PAGE gels.
The gels were silver stained. Specific bands (proteins) which bound only the bgl DNA
but not the control lacZ DNA were cut out, in gel digested with Trypsin and the
resulting peptides were analysed using MALDI-TOF mass spectroscopy in
cooperation with the service laboratory at Cologne molecular medicine center. The
resulting peptide mass data was then analysed using the Profound tool at the Prowl
server (http://prowl.rockefeller.edu/) to identify the corresponding E. coli protein.
A specific protein band of approximate molecular weight 16 kDa (figure 6, lane 2,
black arrow) that could bind only the bgl DNA was identified as H-NS protein of E.
coli. Additional minor differential bands (arrowheads in figure 6) were not
Figure 5: Schematic representation of the bgl
and lacZ DNA fragments used in the affinity
chromatography as "baits". Numbers indicate
nucleotide position with +1 indicating
transcription start site for bgl (a) and first
nucleotide of the structural gene for lacZ (b).
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reproducible. The 16 KDa H-NS band was observed to be binding the bgl fragment
both from total and phosphocellulose prepurified wt cell extracts. On SDS-PAGE gels
this band was found to run at exactly the same position as that of pure H-NS (figure 6,
lane 1). The H-NS band was absent in the negative control with lacZ DNA fragment
(figure 6, lanes 3 and 5). Additionally, the 16 kDa H-NS band was also absent when
cell extracts made from a hns- E. coli strain were allowed to bind the bgl DNA (eg
figure 6, lane 6, white arrow). Thus, it was confirmed that H-NS specifially binds to
the bgl region used in this experiment. However, no additional proteins could be
reproducibly identified that bind specifically to this bgl region. Possible reasons for
this result are that
- the additional proteins binding to the bgl DNA may bind outside of the fragment
used in this experiment. Downstream sequences contribute to bgl silencing in
vivo.
- the in vitro conditions of protein concentration, salt concentration, temperature
and pH used in this experiment may not reflect those found in vivo and therefore
some proteins did not bind the DNA in vitro.
Figure 6: H-NS binds to bgl DNA. Proteins purified by the DNA affinity chromatography were
separated by SDS-PAGE and the gel was silver stained. Cell extracts used were made either from wt
(S541) or hns (S102) strains and either used directly (total protein) or were prepurified over
phosphocellulose as described in the text. The DNA "baits" used were bgl  (lanes 2, 4, 6 and 8) or
negative control lacZ (lanes 3, 5, 7 and 9). Position of the H-NS band is indicated (black arrow, lane
2) which is missing in lane 6 (white arrow). Pure H-NS protein was loaded in lane 1. Positions of the
molecular weight markers are indicated.
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- the unknown proteins may bind the bgl DNA with a weaker affinity or may form a
stoicheometrically minor part of the repressing nucleoprotein complex and thus
could not be purified in concentrations sufficient for detection.
- some proteins involved in bgl regulation, eg FIS are growth phase regulated and
may be present in insignificant amounts in the cell extracts used.
- only H-NS protein binds to the bgl DNA fragment tested and the requirement of
additional cellular factors for in vitro repression of the bgl promoter has
alternative reasons. This possibility is further substantiated in following sections.
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2. Silencing and activation of the Escherichia coli bgl operon are amplified
by the limitation of BglG-mediated antitermination at low transcription rates.
(This section, in part, is in revision for publication to Molecular Microbiology.
Some of the experiments in figures 7 and 11 were carried out by Sandra Kühn.)
Regulation of the bgl operon has been studied quantitatively, mostly using
plasmidic constructs. It is possible that regulation of the bgl operon on multicopy
plasmids is different compared to that on the chromosome (natural situation) eg due to
limiting levels of regulatory factors. To asses this possibility, the bgl operon
expression was studied using a chromosomal system and compared with regulation of
the same constructs on the plasmids. The chromosomal system consisted of either the
natural bgl operon constructs or strains in which the relevant constructs were
integrated in to the chromosomal phage l attachment site attB mediated by the l attP
sequence as described in materials and methods (Diederich et al., 1992).
2.1 Low activation of the chromosomal bgl operon .
Expression levels of the wt bgl operon and of a set of activated derivatives
were determined when encoded on the chromosome or on plasmids (figure 7). The
activated bgl operon
derivatives included
alleles that carries a point
mutation improving the
CRP-binding site (figure
7b, exchange C-66T), an
integration of IS1 (figure
7c), an integration of IS5
(figure 7d), and a deletion
Figure 7: The expression of chromosomally encoded, activated bgl operon derivatives is down-
regulated by limitation of BglG and by RpoS. Phospho-b-glucosidase activities (encoded by bglB)
directed by (a) the wild-type bgl operon and (b to e) activated derivatives were determined when encoded
on plasmids (p15A origin of replication, (Chang and Cohen, 1978)) (plas.) or on the chromosome (chr.).
Cultures were grown in minimal glycerol medium containing the b-glucoside salicin. To provide anti-
terminator BglG in trans (+BglG) transformants of plasmid pKESK10 were grown in medium containing
in addition IPTG. Strains S541 (Dbgl) and S887 (Dbgl, rpoS) were transformed with plasmids (a) pFDX733
(Schnetz et al., 1987), and its Bgl+ derivatives (b) pFDX733-C234 (Schnetz and Rak, 1992), (c) pKESD62
(bgl::IS1-R1243), (d) pFDX733-H3 (Schnetz and Rak, 1992), and (e) pFDY446 (bgl-D2). Chromosomal
strains used were (a) S524 (b) S544, (c) S1245 (d) S1365, (e) S1367, as well as the respective rpoS mutants
(a) S1071, (b) S1079, (c) S1250, (d) S1384, and (e) S1286.
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of the upstream silencer (figure 7e), respectively. The chromosomal wt bgl operon and
two of the activated derivatives (improved CRP-binding site and integration of IS1,
figure 7 b and c) map at the natural locus. The alleles that are activated by integration
of IS5 (figure 7d) and by deletion of the upstream silencer (figure 7e) were integrated
in to the chromosomal phage lambda attachment site attB of strain S541 (relevant
genotype is Dbgl, DlacZ) (figure 7, chr.). Expression levels of plasmid encoded bgl
operon alleles were determined of transformants of strain S541 (figure 7, plas.).
The wt bgl operon expressed low to undetectable levels of phospho-b-
glucosidase activity both when plasmid or chromosomally encoded (figure 7a, 1 unit
and <1unit). Activation of the bgl promoter caused a strong increase (>100 fold) in
the expression level when plasmid encoded (150 to 390 units, Figure 7 plas.), as
reported previously (Reynolds et al., 1981; Schnetz et al., 1987; Schnetz and Rak,
1988; Lopilato and Wright, 1990; Schnetz and Rak, 1992; Schnetz, 1995).
Unexpectedly, in the chromosomal system the expression levels of the activated bgl
operon derivatives were low (2 units) (figure 7 b to e, chr.).
2.2 Construction of a bgl-lacZ reporter system
       To be independent of the b-glucoside specific negative regulation of the anti-
terminator BglG by enzymeIIBgl, bgl-lacZ reporter gene constructs were constructed
(figure 8). The lacZ gene was fused 3' to the bglG gene of the wt bgl operon and of
activated derivatives. Again expression levels were determined when encoded on
Figure 8: bgl-lacZ reporter constructs are
expressed at low levels when encoded on the
chromosome due to limitation of BglG-
mediated antitermination. The b-galactosidase
activity directed by bgl-lacZ reporter constructs
carrying the (a) silent wild-type bgl promoter, (b
to d) activated bgl promoter derivatives, or the
constitutive lacUV5 promoter (e), were
determined when encoded on plasmids (plas.) or
when integrated in to the attB–site (chr.). BglG
(+BglG) was provided in trans by transformation
with plasmid pKESK10 and induction of bglG by
IPTG. Cultures were grown in minimal M9
glycerol medium. Tested were (plas.)
transformants of S541 with (a) pKESD8, (b)
pKESD9, (c) pKESD12, (d) pKESD11, and (e)
pKESD20 and (chr.) strains carrying integrations
of the identical reporter constructs in to attB (a)
S940, (b) S1052, (c) S1054, (d) S942, and (e)
S1095.
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plasmids (figure 8, plas.) and after integration in to the chromosomal attB-site (figure
8, chr.).
In the plasmidic system, the expression of the bgl-lacZ derivatives directed by
activated bgl promoter alleles was significantly increased (17 to 57 fold, 2050 to 6800
units) in comparison to the wt bgl promoter (120 units) (figure 8, compare a to b-d,
plas.). However, when these bgl-lacZ reporter constructs were integrated in to the
chromosome the expression levels directed by the activated promoter alleles were
again unexpectedly low (9 to 16 units) as compared to the wt bgl promoter (7 units)
(figure 8, chr.).
2.3 Low chromosomal expression is not bgl promoter-specific
To test whether low chromosomal expression may be caused by a down-
regulation of the de-repressed bgl promoter alleles in the chromosomal environment, a
lacUV5 promoter lacking the lac operator was introduced. This constitutive lacUV5
promoter (from position -40 to +1) was fused to the transcription start of the bgl
operon (position +1). In the plasmidic system, the lacUV5 promoter directed about
2700 units of b-galactosidase activity (figure 8e, plas.). However, when this lacUV5-
bglt1-bglG-lacZ construct was integrated in to the chromosome the b-galactosidase
activity was again very low (18 units) (figure 8e, chr.). Thus, low chromosomal
expression was found to be not promoter-specific.
2.4 Antiterminator BglG is limiting to expression when encoded on the
chromosome.
The possible reason for high levels of activation on plasmids but not on the
chromosome may be that in the plasmidic system a negative regulator of bgl
expression becomes limiting. Alternatively, in the chromosomal system a positive
regulator, encoded by the bgl operon itself may become limiting due a reduction in
gene dosage. The obvious candidate for the latter possibility was the antiterminator
protein, BglG. Eg BglG is required for antitermination at terminator bgl-t1 in the
lacUV5-bglt1-bglG-lacZ construct (figure 8e). To test whether BglG is limiting to
expression of the activated bgl operon derivatives and bgl-lacZ reporter constructs
when encoded on the chromosome, a low copy plasmid pKESK10 (a pSC101
derivative) was introduced. This plasmid encodes the bglG gene under control of the
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lacUV5-lac operator promoter. In addition, plasmid pKESK10 carries the lacI gene to
allow regulation of plasmid encoded bglG expression which can be induced by IPTG
addition.
The introduction of pKESK10 and induction by IPTG of bglG expression in
trans had little effect on the expression level of the chromosomally encoded bgl-lacZ
construct carrying the wt bgl promoter (figure 8a, +BglG). Interestingly, the
expression of the wt bgl operon (figure 7a, +BglG) increased to 8 units, i.e. to a value
that is higher than the activity of the de-repressed bgl derivatives in the absence of
extra BglG protein (figure 7b to e, chr.). Furthermore, providing BglG in trans led to
a strong increase (20 to 140 fold) in the expression levels of activated bgl operon
derivatives (figure 7b to e, +BglG). In contrast, the expression levels of the plasmid
encoded activated bgl operon derivatives increased less than 1.5 fold when BglG was
provided in trans (unpublished lab results). Likewise, the expression levels of the
chromosomally encoded bgl-lacZ reporter constructs carrying de-repressed bgl
promoter alleles or the constitutive lacUV5 promoter increased significantly (5 to 20
fold) when pKESK10 encoded bglG expression was induced (figure 8b to e, +BglG).
Similar results were obtained when BglG was expressed at higher levels in trans
using a high copy plasmid, demonstrating that BglG levels provided by plasmid
pKESK10 are saturating (unpublished lab results). These data show that the amounts
of BglG synthesized by the de-repressed bgl operon and bgl-lacZ reporter constructs
is limiting for expression when these are encoded on the chromosome.
2.5 Mutation of the bgl terminator t1 to render expression BglG independent
results in high chromosomal expression levels.
To provide further evidence that BglG-mediated antitermination is limiting to
expression, the terminator t1 was mutated in the bgl-lacZ reporter constructs (figure 9
and 10). Antitermination by BglG is mediated by specific binding of BglG to a
secondary RNA structure that overlaps and forms alternatively to the terminator stem-
loop structure, thus preventing termination (figure 9) (Houman et al., 1990; Aymerich
and Steinmetz, 1992). Four site-specific mutants of terminator t1 were constructed.
Mutation DG100 was described previously to render bgl operon expression
constitutive and was used as a control (Mahadevan and Wright, 1987). In addition, a
terminator mutant with three base exchanges in the left stem of the terminator hairpin
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(mutation t1-L), a mutant with three base exchanges in the right stem (t1-R), and the
double mutant (t1-LR) in which the mutations in the left and right stem of the
terminator compensate each other, were constructed. None of these mutations is
expected to disrupt the BglG-binding motif (figure 9 b).
The effect of the mutation of terminator t1 on chromosomal expression levels
was tested using the bgl-lacZ reporter construct that carries the constitutive lacUV5
promoter (figure 10). Terminator mutations t1-L (figure 10 b), t1-R (figure 10 c), and
DG100 (figure 10 e), resulted in high chromosomal expression levels (100 to 150
units). In these mutants providing BglG in trans did not lead to a significant further
increase of in the b-galactosidase activity (figure 10 b, c, and e, +BglG). Expression
Figure 9: Terminator bgl-t1 and
mechanism of antitermination by
BglG. Shown are the secondary
structures and schemes of the rho-
independent terminator t1 (A) and
the mode of antitermination by BglG
(B) (Mahadevan and Wright, 1987;
Schnetz et al., 1987). A: Mutation
DG100 confers a constitutive
phenotype and is likely to disrupt the
terminator (Mahadevan and Wright,
1987). Mutations t1-L and t1-R
disrupt terminator t1 (see Figure 10).
These mutations complement each
other and in the double mutant (t1-
LR) the termination is restored (see
Figure 10). B: Antiterminator protein
BglG binds to an alternative
secondary structure that forms
alternatively to and the terminator
loop and thus prevents termination
(Houman et al., 1990).
Figure 10: Mutation of terminator t1 results in
high expression levels of chromosomal lacUV5-
bgl-lacZ reporter constructs. The effect of
terminator mutations t1-L, t1-R, the double
mutant t1-LR, and DG100 was determined in b-
galactosidase assays after the constructs were
integrated in to the attB-site of strain S541 (Dbgl,
DlacZ). Cultures were grown in minimal glycerol
medium. To test whether expression of bglG in
trans increases expression, the strains were
transformed with pKESK10 and grown in the
presence of IPTG (+BglG). Tested were strains
(a) S1095, (b) S1097, (c) S1099, (d) S1101, and
(e) S1103.
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of the double mutant (t1-LR) was low in the absence of additional BglG protein and
induction of bglG expression in trans caused an increase of the expression level
similar to the wt terminator construct (compare Figure 10 a and d). In case of
terminator mutation t1-L (figure 10b) the b-galactosidase activity (150 units) was
~1.5 fold higher than in case of the other constructs (figure 10). This small effect may
relate to eg a changed RNA-stability and was not followed further.
2.6 A moderate (3-fold) effect of RpoS on the transcription rate can result in
an up to 50 fold increased expression levels of activated bgl operon derivatives
Silencing of the bgl operon requires H-NS, as an essential component, and
may involve StpA, Hfq, RpoS, and Fis (see introduction). The effect of RpoS (using a
rpoS359::Tn10 mutant) was tested on expression of the bgl operon (figure 7) and of
the BglG-independent bgl-lacZ reporter constructs carrying the mutated terminator
t1-L (figure 11). The expression levels of the chromosomal bgl operon derivatives
activated by an improved CRP-binding site and by integration of IS1, respectively,
increased 40 to 50 fold in the rpoS mutant (figure 7b and c). The wt operon (as
observed previously (Ohta et al., 1999) and derivatives activated by integration of IS5
or deletion of the upstream silencer
remained low in the rpoS mutant
(figure 7a, d and e). Interestingly,
these two activated alleles were
also expressed at significantly
lower levels when BglG protein
was provided in trans (figure 7d
and e). RpoS had a minor effect
(less than 1.5 fold) on the plasmid
encoded bgl operon (figure 7). In
contrast, the expression level of all
BglG-independent chromosomal
bgl-lacZ reporter constructs
carrying the wt or activated
promoters increased 2.5 to 3 fold
(figure 11). RpoS had a similar
Figure 11: BglG-independent bgl-lacZ reporter
constructs are down-regulated 3 fold by RpoS. The
terminator mutation t1-L was introduced in to bgl-lacZ
reporter constructs carrying the wild-type bgl promoter
and activated promoter derivatives. b-galactosidase
activities were determined in the wild-type strain
background and a rpoS359::Tn10 mutant from cultures
grown in minimal M9 glycerol medium. (a) S1142 and
S1155 (= S1142 rpoS359::Tn10), (b) S1144 and
S1157, (c) S1148 and S1161 and (d) S1146 and S1159.
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effect on these bgl-lacZ reporter constructs when plasmid encoded (unpublished lab
results). Thus, an approximately 3 fold contribution of RpoS to regulation of the bgl
operon could be either amplified in to a strong (~50 fold) increase in the expression
level of the bgl operon or remained undetectable if the initial transcriptional level was
low. The lacUV5 promoter bgl-lacZ construct was regulated two-fold by RpoS (figure
11e) indicating that RpoS affects the bgl operon indirectly and moderately at the bgl
promoter.
In Glucose minimal medium, catabolite regulation of the CRP mediated bgl
promoter was seen. Also, the catabolite control of BglG mediated antitermination was
found to be significant in glucose medium as previously known (unpublished lab
results) (Görke and Rak, 1999; Gulati and Mahadevan, 2000).
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3. A mutagenesis screen to identify factors involved in regulation of the bgl
operon.
Regulation of the bgl operon is known to occur via at least two phenomena,
namely, silencing of the bgl promoter and substrate specific transcriptional
termination/antitermination. According to the nucleoprotein repressor complex model,
(Schnetz, 1995; Schnetz and Wang, 1996; Caramel and Schnetz, 1998). H-NS and
possibly more unknown proteins are required for silencing of the bgl promoter. In
order to identify these unknown additional proteins a genetic screening strategy based
on random transposon (miniTn10) mediated mutagenesis was carried out as follows.
The mutagenesis screen was done in two ways. First mutagenesis was
performed and mutants
causing de-repression of
the wt bgl operon were
screened. Secondly, a
reverse screen was
performed for mutations
which downregulated
active bgl operon
expression. To avoid
mutations in cis, a double
phenotype screen strategy
was used. This strategy
yielded mutants with
double phenotypic change
that have a in trans
mutation.
For introducing
mutations, a l phage
vehicle carrying a
miniTn10 transposon
with a tetracycline
resistance marker was
Figure 12: Mutagenesis screen strategy (a) The starting tester
strain of E. coli has the natural bgl operon. It also has the lac
promoter-operator region replaced by a cassette consisting of the
upstream bgl silencer, the bgl promoter and the downstream
silencer. In this reporter the bgl leader sequence is deleted for
terminator t1 (spanning the nucleotides +55 to +120 relative to the
transcription start) and the bglG gene is mutated to orfG. (b) In
one experiment a tester strain (S581) carrying the silent wt bgl
promoter at both the positions (phenotype Bgl-, Lac-) was
mutagenised and screened for a double phenotypic conversion to
(Bgl+, Lac+). All such Tn10 insertion mutations mapped in the hns
locus. In a reverse screen, a tester strain (S594) carrying an
activated bgl promoter allele (allele C234) at both positions was
mutated and screened for a phenotypic conversion from Bgl+,
Lac+ to Bgl-, Lac-. This strategy yielded mutants carrying
transposon insertions  in the pgi, lon and hfq and cyaA loci.
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used (Kleckner et al., 1991). The l phage vehicle contains nonsense mutation in the l
repressor gene and a deletion of the phage integration system. Thus, it can only
introduce the miniTn10 in to the E. coli chromosome but can not enter the lytic cycle
of growth nor can it become a prophage. The gene coding for the transposase enzyme
required for Tn10 insertion in to the chromosome is encoded on sequences outside the
miniTn10 itself and thus lost along with other l sequences. Therefore the miniTn10
transposon can transpose in to the chromosome only once.
A starting tester strain of E. coli (S581) was constructed. This strain (figure
12) has the natural wt bgl operon (Bgl-). It also has the lac promoter-operator region
of the lac operon replaced by a cassette consisting of the upstream bgl silencer, the
bgl promoter with the bgl leader sequence and the bglG gene. This bgl leader
sequence has a deletion spanning the nucleotides +55 to +120 relative to the
transcription start. Thus, the terminator t1 is deleted. In addition, the start codon and
two additional ATG (codon 3 and 27) of bglG are mutated (ATG to GCG). Therefore
the bglG gene (orfG) can be transcribed but not translated. The fusion of the wt
(silenced) bgl promoter renders the lac operon silent. Thus, the tester strain has a
starting phenotype of Bgl- , Lac-. After transposition, the tester strain mutants
(Tetracycline resistant) were plated on to MacConkey Lactose Tetracycline plates and
those mutants with a change in phenotype from Lac- (white colonies) to Lac+ (red
colonies) were purified and restreaked on BTB Salicin plates to score for the Bgl
phenotype change from Bgl- (white colonies) to Bgl+ (orange colonies). From a total
of more than 50,000 mutants scored, 6 mutants showed a double phenotypic change
from Bgl-, Lac- to Bgl+, Lac+. The insertion position of miniTn10 transposon on the
chromosome was determined by direct genomic sequencing using a miniTn10 specific
primer (S156) or by sequencing of the PCR amplified mutated region. All the 6
mutants above were found to map in the hns locus. The insertion of miniTn10 in the
hns locus presumably causes a disruption of the hns gene and absence of active H-NS
in these cells leads to activation of the bgl promoter as known before (Higgins et al.,
1988).
A reverse strategy was adopted to identify those genes required for the
expression of the bgl operon when the promoter has been activated by a mutation in
the bgl silencer region. For this experiment a double reporter tester strain (S594) was
constructed. It was similar to the tester strain described above except that an activated
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allele of the bgl promoter was used both at the bgl operon and the lac operon loci.
This bgl promoter allele has mutation C234 (see introduction), which improves the
CRP binding site and thus derepresses the bgl promoter (figure 12). The starting
phenotype of this strain was Bgl+, Lac+. It was mutagenised by random miniTn10
insertion and mutants with double phenotypic conversion to Bgl-, Lac- were
identified. A total of 16 such mutants were identified from more than 1,00,000
mutants screened. The insertion position of miniTn10 transposon on the chromosome
was determined by direct genomic sequencing using a miniTn10 specific primer
(S156) or by sequencing of the PCR amplified mutated region. The mutated/disrupted
genes were (strain number)
- cyaA (1 mutant)  : mutation number 152 (S756)
- pgi (5 mutants)  : mutation numbers 111 (S751), 112 (S752), 123
                                       (S753), 132 (S755), 194 (S765)
- lon (7 mutants)          : mutation numbers 108 (S749), 124 (S754), 166
                                       (S759), 172 (S760), 183 (S762), 187 (S764), 204
                                       (S766)
- miaA/hfq (3 mutants) : mutation numbers 110 (S750), 155 (S757), 184
                                      (S763)
The miniTn10 insertion positions in the lon and miaA/hfq loci are shown in figure 13.
Figure 13. The miniTn10 insertion positions  in
the lon and miaA/hfq  loci. Mutation numbers are
indicated. Numbers in brackets indicate the
miniTn10 insertion position relative to the lon
structural gene nucleotide position, (a) and
according to nucleotide numbering in Genebank
entry Primary acc No.: gb|AE000489|ECAE000489
(b). Previously described hfq mutations, W1 and W2
are also shown (b).
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From the 16 mutants, one mapped in the cyaA gene which codes for the adenylate
cyclase enzyme catalyzing production of cyclic AMP (cAMP). Due to a lack of
cAMP in this strain the active CRP-cAMP complex can not form and bind the CRP
binding site of the bgl promoter thereby causing low or no expression. This mutation
was not further analyzed. Mutations obtained in the other three loci (pgi, lon and hfq)
were further analyzed to determine the specificity of their effect on the expression of
the bgl operon.
The tester strain (S594) was used to quantitate the effect of these mutations on
the expression of the PbglC234-D(55-120)-orfG-lacZYA construct by measuring the b-
Galactosidase activity. For comparison the effect of the mutations on the expression
of the wt lac operon (strain S539) was also measured (figure 14).
3.1 The pgi mutation specifically downregulates bgl expression.
The pgi gene codes for the enzyme Phosphoglucoisomerase of the glycolysis
pathway. This mutation results in a decreased expression of the bgl operon construct
as shown in figure 14. However, expression levels of the wt lac operon were not
significantly altered by the pgi mutation. Thus, pgi mutation specifically
downregulates the bgl operon expression. It was recently shown that in a pgi mutant,
glycolysis is blocked and this accelerates RNaseE mediated degradation of the ptsG
gene transcript. The ptsG gene codes for a transport protein for Glucose uptake and is
a part of the PTS transport system (Kimata et al., 2001).
Figure 14: Mutations in lon, pgi and hfq genes specifically downregulate the bgl expression.
Expression levels of a) the C234-Pbgl D(55-120) orfG lacZ construct (S594) and b) the wt lac operon
(S539) were measured in various mutantion backgrounds obtained during the screen.
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3.2 The lon mutation specifically downregulates bgl expression.
Lon is a ATP dependent protease and it has been shown that Lon can
specifically degrade StpA protein of E. coli which is 67% similar to the H-NS protein
(Johansson and Uhlin, 1999) (see introduction).
As seen in figure 14, different lon mutations obtained during the screen
resulted in approximately 3 fold lower expression of the bgl-lacZ construct. These
mutations did not significantly alter expression of the wt lac operon. Thus, lon
specifically downregulates bgl expression. One of the lon mutations, lon187 which
maps closest to 5´end of the lon gene was selected for further analysis (figure 13). The
lon mutation can affect expression of the bgl operon in following way. Lon protein
presumably degrades a protein which has a negative effect on expression of the bgl
operon. Thus, in a lon mutant this negative regulator protein is stabilized and can
accumulate to higher levels causing low bgl expression. As mentioned above protein
StpA is a possible candidate for this negative regulator. Although the role of StpA in
bgl regulation is not clear, it is possible that StpA can exert its negative role only
when present in high levels as may be found in lon mutant cells. In order to determine
whether the effect of Lon protease is due to accumulation of StpA in the cells,
attempts were made to construct a lon, stpA double mutant strain by T4 phage
mediated transduction. However, all such attempts failed. The probable reason may be
that in the double mutant cells, levels of the cell division negative regulator protein
SulA are high resulting in complete inhibition of cell division and thus causing a
lethal phenotype. Experiments using a sulA mutant strain to combine the lon and stpA
mutations indicated that the positive effect of Lon on bgl expression is independent of
StpA (Klingen and Schnetz, unpublished results).
3.3 The hfq mutations specifically downregulate bgl expression.
Gene hfq codes for Host Factor for replication of RNA phage Qb (Hfq). It is a
15KDa protein with ~30000 molecules/cell (Ali et al., 1999). Hfq has a RNA
binding/chaperone activity. It has been shown to bind to and decrease the stability of
ompA mRNA (Vytvytska et al., 1998; Vytvytska et al., 2000). Hfq also binds to the
rpoS mRNA and is essential for the translation of this mRNA (Muffler et al., 1996;
Zhang et al., 1998). All the mutations mapping in the hfq region had a specific
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negative effect on expression of the bgl-lacZ construct of strain S594 (figure 14).
There was no significant effect on the expression of the wt lac operon.
3.4 The hfq155 is a true hfq- mutation.
The hfq gene is a part of the complex amiB-mutL-miaA-hfq-hflX operon.
Regulation of this operon is not completely understood. It has been shown to have
multiple promoters which cause expression of different genes of the operon to various
degrees (Tsui et al., 1994). Out of the three mutations in this operon isolated during
the screen, two mapped in the miaA gene and one (hfq155) mapped in the hfq gene
(figure 13). Thus, it was necessary to determine whether these mutations affected bgl
expression due to a defect in expression of the hfq gene or other genes of this operon.
Effect of mutation hfq155 on bgl expression was compared to that caused by two
previously described mutations hfq1::W and hfq2::W. Both these mutations are
insertions of a W cassette containing kanamycin resistance marker and strong
Figure 15: Mutation hfq155 affects the bgl expression similar to hfqW1. The effect of mutations
hfq155, hfqW1 and hfqW2 was determined in b-Galactosidase assays on the constructs integrated in to
the chromosomal attB site. All the constructs have a deletion spanning +55 to +120 relative to
transcription start. In constructs a and c the wt bgl promoter is present while constructs b and d
contain a bgl promoter allele activated by deletion of the upstream silencer (D2). Furthermore, in
constructs a and b the start codon and two additional ATG (codon 3 and 27) of bglG (orfG)  are
mutated (ATG to GCG). In constructs c and d, the bglG gene is absent and is replaced by lacZ. Strains
used were in the order wt, hfq2::W , hfq155, hfq1::W  a) S397, S841, S891, S833 b) S403, S843, S893,
S835 c) S387, S837, S790, S829 d) S393, S839, S792, S831.
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rho-independent transcriptional terminators. In hfq1::W , the W cassette is inserted
towards the 5 -´end of the hfq gene thus causing a Hfq- phenotype. In hfq2::W the W
cassette is inserted towards the 3 -´end of hfq gene resulting in a active Hfq
expression. However, both mutations have the same polar effects on expression of the
downstream genes (Tsui et al., 1994) (figure 13). As shown in figure 15, mutation
hfq2::W had no significant effect on bgl expression. Whereas, mutation hfq1::W had a
negative effect on bgl expression very similar to that of hfq155. Thus, it was
concluded that hfq155 mutation and presumably other mutations obtained during the
screen in the same region are indeed phenotypically Hfq-. Although they may still
differentially affect expression of other genes in this locus, it is their effect on hfq
expression that results in lower bgl expression. Thus, hfq mutation causes specific
downregulation of bgl expression. One of the hfq mutations, hfq155 which maps in
the hfq gene was selected for further analysis.
3.5 The effect of hfq on bgl expression is independent of the bgl promoter,
termination/antitermination and RpoS.
Hfq is required for translation of the rpoS mRNA (Muffler et al., 1996). RpoS
is the alternative stationary phase specific sigma factor of E. coli RNA polymerase
and its expression is upregulated during starvation and upon transition in to the
stationary phase of E. coli growth. RpoS-RNA polymerase holoenzyme causes
transcription and expression of certain starvation stress induced and stationary phase
specific genes involved in adaptation of the cell to changes in the environmental
conditions (Hengge-Aronis, 1996).
Hfq possibly binds to rpoS mRNA and changes its tertiary structure to
facilitate ribosome binding and translation. In the absence of Hfq, 5'-end of the rpoS
mRNA forms a closed loop structure preventing ribosomal access to the ribosome
binding sequence (RBS) on the mRNA. Presumably, Hfq binding prevents formation
of this loop structure and opens up the 5' mRNA end of the mRNA making the RBS
accessible (Muffler et al., 1996; Zhang et al., 1998).
Mutation of the rpoS gene can positively affect bgl expression (Ohta et al.,
1999). In the hfq mutants, the RpoS expression is low. To substantiate that the effect
of Hfq on bgl expression is independent of RpoS, bgl expression was measured in hfq,
rpoS and hfq,rpoS double mutant strains (figure 16). In this experiment wt (a) and
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activated (D2 and IS5-insertion) bgl promoter alleles were used (figure 16, constructs
b and c, respectively). Additionally, a heterologous constitutive promoter (lacUV5)
was used instead of the bgl promoter (construct d). In construct e, the terminator t1-L
mutation (described in results section 2) was used to render the expression
independent of BglG mediated antitermination. In all the cases, rpoS mutation
positively affected bgl-lacZ expression (compare columns wt and rpoS). A significant
negative effect of hfq mutation was seen only in b, c, d, and e (compare columns wt
and hfq). It should be noted that in hfq mutant cells, low level RpoS expression is
possible. Thus, to determine the effect of absence of only Hfq in a constant RpoS
background, expression levels in rpoS and hfq, rpoS double mutant strain should be
compared (columns rpoS and hfq, rpoS). Such an analysis showed that when Hfq was
absent with no possible change in RpoS activity (nil), the bgl expression was
downregulated upto 3 fold for the wt bgl promoter construct (a) and for the other
constructs carrying an active promoter (b and c). Thus, it can be concluded that the
negative effect of hfq mutation on bgl expression is independent of RpoS.
The analysis in figure 16 also shows that the Hfq effect is independent of the
bgl promoter. Even when a heterologous lacUV5 promoter was used (d) instead of the
Figure 16: Hfq effect is independent of the promoter, termination/antitermination and RpoS. The
b-Galactosidase expression levels of various chromosomally integrated (attB:) constructs (a to e) and
the wt lac operon (f) were measured in wt, hfq, rpoS and hfq, rpoS  mutation backgrounds. Strains used
were in the order wt, hfq , rpoS and hfq,rpoS a) S1142, S1402, S1155, S1404 b) S1146, S1406, S1159,
S1408 c) S1148, S1410, S1161, S1412 d) S1095, S960, S1130, S1414 e) S1097, S1311, S1132, S1416
f) S539, S1418, S1107, S1420.
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bgl promoter (a, b and c), a similar hfq effect was observed. Also the disruption or
deletion of the upstream bgl silencer sequence in b, c and d did not change the hfq
effect. In construct d the wt terminator t1 is present while in construct e, the
terminator t1-L mutation prevents the transcriptional terminator loop formation. Both
these constructs show a similar fold hfq effect. It is possible that in construct c, the
expression increases if extra BglG is provided in trans. However, it can be concluded
that the effect of hfq mutation on bgl expression is independent of the upstream bgl
silencer, the bgl promoter and termination/antitermination at t1. There was no
significant Hfq effect on expression of the control lac operon (construct f).
3.6 Effect of hfq depends on the presence of bglG sequence.
The effect of hfq on the
expression of various bgl constructs
was studied as in figure 17. All the
constructs had a heterologous lacUV5
promoter and t1-L mutation since hfq
effect was shown to be independent of
the promoter and antitermination.
The lacZ reporter gene was
fused downstream of the bglG gene as a
transcriptional fusion (constructs a to e)
in which translation of the lacZ mRNA
is facilitated by its own ribosome
binding site (RBS lacZ). In construct b,
the start codon and two additional ATG
(codon 3 and 27) of bglG are mutated
(ATG to GCG). Therefore, the bglG
gene (orfG) can be transcribed but not
translated. The constructs c, d and e had
15, 5 or none of the 5´codons of the
bglG gene, respectively. In c and d, a
stop codon was added at the ends of the
truncated bglG genes.
Figure 17: The Hfq effect is bglG sequence
dependent. The b-Galactosidase expression
levels from various plasmidic constructs were
measured in wt and hfq strains. The plasmids used
were a) pKESD28, b) pKESD47,  c) pKESD44,
d) pKESD42, e) pKESD36, f) pKESD39, g)
pKESD45, h) pKESD43 and i) pKESD24.
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 In constructs f to i, the lacZ gene was fused to the bglG gene as a translational
fusion so that LacZ is translated as a fusion protein along with BglG. In f, the entire
bglG gene without the last stop codon is fused to the 5´-end of lacZ gene. In
constructs g, h and i only 15, 5 or none of the 5´codons of the bglG gene are present
and are translationally fused to the lacZ gene. In i, lacZ gene is translated using the
RBS of bglG gene.
The expression levels of these constructs were measured in wt and hfq cells.
Absence of the entire bglG gene sequence caused a upregulation of expression in wt
cells (figure 17, compare wt expression of c, d, e to a and h, i to f). Thus, the bglG
gene was shown to cause a polar effect on expression of the downstream (lacZ) gene.
This negative polar effect was higher in construct b, when orfG was not translated.
The negative effect of hfq on bgl expression was seen only when the entire
bglG sequence was present (constructs a and f). The effect was also seen when only
orfG was present but not translated (b). However, in all other cases when complete
bglG sequence was absent the hfq effect was lost (c, d and e) or reversed (g, h, i).
Thus, it was concluded that hfq effect depends on the presence of complete bglG
The mRNA structures of the (bglG-lacZ) translational fusion constructs.
Computer analysis of the mRNA structures of (bglG-lacZ) translation fusions was
performed using the mfold software (http://bioinfo.math.rpi.edu/~mfold/rna/)
(Zucker et al., 1999) The mRNAs of translational fusion constructs carrying all or
the first 15 amino acids of BglG had a structure (left) with three stem loops, the
first loop is the BglG binding domain, the second loop is the remnant of the
terminator t1 loop prevented from forming completely and the third loop
containing the ribosome binding site (RBS) and the start codon (AUG) of bglG.
This closed structure can possibly downregulate translation of BglG. In contrast,
the mRNA of a translational fusion construct carrying only the first 5 amino acids
of BglG had a open structure (right) with the first two stem loops similar to the
closed structure and the third loop shifted upstream such that the RBS and start
codon of bglG are accessible.
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sequence. It should be noted that in construct b, when orfG is not translated hfq still
downregulated the expression. Thus, the effect of hfq on bgl expression is
independent of bglG translation.
Moreover, Hfq positively affects bgl expression both when transcriptional (a)
and translational fusion (f) reporter constructs are used. Thus, Hfq protein plays its
regulatory role before the translation process. Since, the Hfq effect is independent of
the promoter, it probably does not affect transcription initiation. Hfq is a known RNA
binding protein and has RNA chaperone activity and it is conceivable that it affects
either the stability or the structure of bgl mRNA.
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4. H-NS regulates expression of the bgl operon at multiple levels.
The histone-like protein H-NS is essential for silencing of the bgl operon
(Defez and de Felice, 1981; Higgins et al., 1988).  H-NS represses the CRP/cAMP
dependent bgl promoter, where it is likely to bind to a AT-rich silencer sequence
located upstream of the CRP-binding site (Schnetz, 1995; Schnetz and Wang, 1996;
Mukerji and Mahadevan, 1997) and putatively forms an extended repressing
nucleoprotein complex (Caramel and Schnetz, 1998). The wt bgl operon is activated
in a hns mutant strain presumably due to de-repression of the wt bgl promoter. Indeed,
in vitro DNA binding studies using mobility shift and DNaseI protection
(footprinting) experiments indicated that H-NS specifically binds to the bgl upstream
silencer DNA (Wahle and Schnetz, unpublished results).
It has been shown that sequences downstream of the bgl promoter contribute
significantly to silencing of the bgl operon (Schnetz, 1995). The mechanism of this
observation is not clear. As shown in results section 2, requirement of threshold BglG
levels contributes towards regulation of the bgl operon. However, additional
mechanisms of regulation acting at the promoter downstream sequences are possible.
Expression of different chromosomally integrated (attB) bgl constructs was
upregulated by hns mutation. As shown in figure 18, hns mutation increased
expression by 26 and 7 folds, respectively when wt and an a de-repressed allele of the
bgl promoter directed the expression of a lacZ reporter construct. (figure 18,
constructs a and b, respectively). The effect of H-NS on the bgl promoter and the
upstream silencer element is shown in figure 18, constructs g - j. The expression of
these constructs was measured in NB medium unlike constructs a - f which were
measured in LB2Y medium. This was to avoid trace amounts of glucose which may
be present in LB2Y medium and which can cause catabolite repression of the bgl
promoter. In constructs g - j, the bgl sequence only upto +25 (relative to transcription
start) is present. In construct g, the upstream silencer element is present and hns
mutation upregulates expression of this construct 4 fold. When the upstream silencer
is deleted (figure 18, construct h) or when the CRP binding site is improved (construct
i), bgl expression in the wt strain is 4 to 5 fold high as compared to the wt promoter
construct (construct g). However, hns mutation does not change the expression levels
of constructs h and i significantly. In construct j, the upstream silencer is deleted as
well as the CRP site is improved. It was seen that these two independent mutations
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known to de-repress the bgl promoter have an additive de-repressive effect on the bgl
promoter since the expression levels of construct j in the wt strain is higher than
constructs h and i which have the individual mutations. Expression of construct j is
also not significantly altered in the hns strain. Thus, it can be concluded that H-NS
mediated repression of the bgl promoter operates via the upstream silencer. When the
upstream silencer is deleted (construct h) or when binding of H-NS to the upstream
silencer is presumably counteracted by improved binding of CRP (construct i), H-NS
has no effect on the bgl promoter.
When the bgl promoter was replaced by a constitutive lacUV5 promoter and
the upstream silencer was absent (figure 18, construct c), hns mutation caused a
upregulation by 14 fold. This construct has the wt terminator t1, therefore it is
possible that in the presence of extra BglG in trans the expression levels are higher
both in the wt and the hns cells. Still, this indicates that H-NS has a negative effect on
Figure 18: H-NS mediated
downregulation of bgl expression
via upstream and downstream
silencers.  The b-Galactosidase
activity directed from various bgl
constructs was measured in wt and
hns strains. Cultures were grown in
LB2Y medium (a-f) or NB medium
(g-j). Strains used were in the order
wt, hns a) S1142, S1467 b) S1146,
S1469 c) S944, S1307 d) S1097,
S1309 e) S1189, S1252 f) S1191,
S1254 g) S1213, S1471 h) S1211
S1473 i) S1215, S1475 j) S1217,
S1477.
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bgl expression in addition to that on the bgl promoter. When the terminator t1 was
mutated to t1-L (figure 18, construct d), hns mutation caused upregulation of
expression by 4 fold showing that H-NS mediated downregulation is independent of
the termination/antitermination. In figure 18, construct e, the start codon and two
additional ATG (codon 3 and 27) of bglG are mutated (ATG to GCG) such that the
bglG gene (orfG) can be transcribed but not translated. Expression of this construct is
upregulated 10 fold in the hns mutant. Thus, the negative regulation by H-NS is
enhanced in the absence of translation of bglG. However, when the bglG gene is
deleted (construct f), the hns mutation has no effect on the lacZ expression. Thus, the
H-NS protein possibly exerts its negative regulatory effect on expression of the bgl
operon at multiple levels: In addition to its known role in repression of the bgl
promoter it acts on the sequences downstream of the promoter. The bglG gene
sequence is essential for this downstream role of H-NS. Possible mechanisms of
H-NS mediated downregulation at the downstream sequences are
- prevention of transcription initiation by DNA binding. However, it has
been shown that H-NS does not specifically bind DNA sequences
downstream of the bgl promoter (Wahle and Schnetz, unpublished results).
- inhibition of transcription elongation through the leader and bglG
sequence
- RNA destabilization
The effect of H-NS is stronger when bglG is not translated (orfG) (figure 18,
construct e). To test the possibility whether H-NS effects bgl mRNA stability, S1
nuclease protection studies were carried out as described below. The H-NS mediated
repression via the upstream silencer is maximum 4 fold (construct g). Interestingly,
H-NS mediated downregulation of the bgl operon via the downstream silencer can be
upto 14 fold (construct c). Thus, it can be concluded that the majority of the H-NS
mediated downregulation of the bgl operon is via the downstream silencer. It should
be noted that when the terminator t1 is mutated thus rendering the bgl expression
independent of BglG mediated antitermination (construct d), effect of H-NS is 4 fold.
Thus, H-NS mediated downregulation of bgl expression via the downstream silencer
is presumably enhanced due to limiting BglG levels.
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4.1 HNS mediated regulation on plasmids.
The negative
regulation by H-NS via the
downstream silencer was
possibly due to bgl RNA
destabilization. It was
necessary to use plasmidic
constructs for RNA analysis
in order to obtain RNA
yields sufficient for
detection. Regulation of
plasmid encoded bgl
constructs by H-NS was
found to be similar to that of
chromosomally encoded
constructs (figure 19).
Expression of the plasmidic
bgl construct with the
constitutive lacUV5 promoter and the wt terminator t1 was upregulated 6 fold in hns
strain (construct a). A similar effect was seen when terminator t1 was mutated to t1-L
(construct b). In construct c, the start codon and two additional ATG (codon 3 and 27)
of bglG are mutated (ATG to GCG) such that the bglG gene (orfG) can be transcribed
but not translated. Expression of this construct was upregulated 10 fold in the hns
mutant. However when the bglG gene was deleted (construct d), the hns mutation had
no effect on bgl expression. Thus, plasmids like pKESD28 (figure 19, construct b)
could be used for further analysis.
4.2 H-NS causes destabilization of the bglG mRNA.
S1 nuclease protection assay was used to quantitate bgl mRNA levels. The
amounts of bgl mRNA from plasmidic construct pKESD28 (figure 19, b) were
quantitated in wt and hns strains. The outline of S1 nuclease protection assay
experiment is shown in figure 20. S1 nuclease is a single strand specific endonuclease
and it can not act on double stranded RNA, DNA or RNA-DNA hybrids. The bgl
mRNA was probed at four different regions namely, in the leader and at three
Figure 19: H-NS mediated regulation of plasmid
encoded bgl constructs. The wt (S541) and hns (S614)
strains were transformed with plasmids with the shown
bgl-lacZ reporter constructs. Cultures were grown in
LB2Y medium and the b-Galactosidase activities
measured. Plasmids used were pKESD20 (a), pKESD28
(b), pKESD47 (c) and pKESD36 (d).
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positions along the bglG gene (figure 20, b). For accurate quantitation of mRNA,
internal recovery control RNAs were used (figure 20, a). The control RNAs normalize
differences in RNA yields, differences in labeling efficiencies, variations in
hybridization efficiencies and other experimental and autoradiography variations.
These control RNAs correspond to the indicated sequences of the bgl operon with
additional non-bgl lac operator sequences at their 5' ends (gray regions in figure 20).
The DNA fragments corresponding to the control RNAs were cloned in a high copy
plasmid (pKESD65, pKESD53, pKESD54 and pKESD55, see figure 20, b) such that
a IPTG inducible tac promoter directed their transcription. The non-bgl sequences at
the 5´-ends correspond to the lac operon leader sequence. For control RNA
preparations total RNAs were prepared using the hot phenol method from wt strain
(S541) transformed individually with the above four plasmids and induced with 1mM
IPTG. Fixed amounts of each control total RNA (100mg each) were added during the
preparation of pKESD28 RNA from wt (S541= Dbgl DlacZ) and hns (S614= Dbgl
DlacZ hns::ApR) strains as described in materials and methods. Briefly, wt or hns
strain transformed with pKESD28 was grown in LB2Y medium till OD600 ~ 0.5.
Figure 20: Principle of S1 nuclease protection assay. a) Experimental and control RNAs are
hybridized together with the single stranded radiolabeled DNA probe. The non hybridized RNAs and
probe regions are digested using S1 nuclease. The protected probe fragments are run on a sequencing
gel. b) The bgl mRNA was probed at four regions, in the leader and at three positions along the bglG
gene. The bgl sequences present in the control RNAs are shown by the nulcleotide positions relative
to  transcription start.
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Rifampicin was added (time 0) to 100mg/ml stopping new transcription initiation and
20ml samples were taken at different time points. These were quickly added to a
pre-heated phenol, SDS mix containing 100mg each of the four control RNAs. The
RNAs were then further extracted and purified as described in materials and methods.
The DNA in these preparations was digested using RNase free DNaseI. Finally,
200mg total RNA from each sample was used for S1 analysis. The plasmids
pKESD65, pKESD53, pKESD54 and pKESD55 were also used to synthesize single
stranded internally radiolabeled (P32) DNA probes using suitable primers and
T7-DNA polymerase. Thus, each probe could hybridize to the entire control RNA
from that plasmid and also to a corresponding shorter sequence on the bgl mRNA.
After hybridization, S1 nuclease digestion was performed such that the nonhybridized
single stranded regions of the DNA probe as well as any unhybridized RNA are
digested away. When run on urea:acrylamide sequencing gels two bands
corresponding to the radioactive probe protected by the control RNA (larger band)
and probe protected by the bgl mRNA (smaller band) were seen (for details see
materials and methods).
The band intensities were then quantitated using a Fuji BAS1000
phosphorimager and the gels were also auto-radiographed. The experimental band
intensities were normalized with the control band intensity from the same lane. After
correcting for background in each lane and for the OD600 of the culture, the intensities
were expressed as percentage of the normalized intensity of experimental band for
that gel from hns cells at time 0 of rifampicin addition (100%). Figure 21 shows
results of such an experiment. Averages of the normalized band intensity values from
two independent experiments were plotted against time after rifampicin addition and
these plots were used to calculate the half life values of the bgl mRNA (figure 21).
It was observed that the half life of the leader part of the bgl mRNA was not
significantly different in wt (3.3minutes) and hns (2.8minutes) strains. However, the
mRNA half life of the three bglG regions were approximately half in wt cells as
compared to that in the hns cells. Thus, it can be concluded that in wt cells presence of
H-NS causes a 2-fold reduction in the stability of bglG mRNA. However, there is no
effect of H-NS on the stability of the bgl leader RNA.
H-NS can differentially affect the stabilities of different parts of the same
RNA due to various reasons. It is possible that H-NS can directly interact with only
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part of the mRNA making it unstable. It is also possible that there are
endonulease sites between the leader and bglG parts of the mRNA and after
endonucleolytic cleavage the leader mRNA is stable whereas the bglG part which
may interact with H-NS is destabilized. Results obtained using the probe hybridizing
with the 3'-end of bglG mRNA were not accurate and should be reconfirmed using a
different primer.
The differential effect of H-NS on the leader mRNA and bglG mRNA is in
agreement with the in vivo results in figure 18. The hns mutation had an effect on bgl
expression only when the bglG sequence was present (figure 18, constructs a, b, c, d
and e) but not when the bglG sequence is deleted (construct f) although the bgl leader
sequence is present.
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IV. Discussion
1. Multiple levels of the bgl operon regulation.
In the present work the bgl operon of E. coli was shown to be regulated at
multiple levels as shown schematically in figure 22. The bgl promoter is repressed by
formation of a nucleoprotein complex of which H-NS forms an essential and
dominant component. Formation of the repressor complex involves the upstream
silencer and the promoter regions. In the promoter downstream region two additional
levels of regulation operate. The BglG protein causes antitermination at the terminator
t1 and threshold cellular levels of BglG are required for efficient antitermination. This
threshold can amplify silencing and activation of the operon at low expression levels.
A new dominant theme of bgl regulation is regulation of mRNA stability. H-NS
causes destabilization of the bglG mRNA and other factors like Hfq, Pgi and
translating ribosomes also play a part in regulating the bgl mRNA level. Evidences for
each level of regulation are discussed below.
Figure 22. A new model showing multiple levels of the bgl operon regulation. Left, the wt bgl operon
is silenced. H-NS, possibly alongwith other proteins like FIS binds the upstream silencer and the
promoter regions causing transcriptional repression. Basal levels of transcription initiation events mostly
result in transcriptional termination at t1. A leakthrough may result in low transcription of the
downstream sequences. H-NS causes destabilization of such bglG mRNA and eclipses a presumed
positive Hfq effect on the mRNA stability and further reduces the expression. Background levels of BglG
protein which may result are not sufficient for efficient antitermination. Right, in the case of an activated
bgl promoter allele (eg improved CRP site allele) CRP binding with higher affinity destabilizes the H-NS
containing repressor complex. RNA polymerase (RNAP) can gain access to the promoter and
transcription initiates. The resulting higher BglG expression causes efficient antitermination resulting in
still higher BglG amounts thus starting an expression amplification loop. H-NS and Hfq still act
negatively and positively on the mRNA stability, respectively. The translating ribosomes and Pgi
presumably also cause mRNA stabilization.
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2. Repression of the promoter.
It has been proposed (Caramel and Schnetz, 1998), that H-NS binds the
upstream AT-rich sequence and presumably promotes the formation of a silencing
nucleoprotein complex involving Fis and possibly other unknown cellular factors
(Schnetz, 1995). In the present work an attempt was made to identify the additional
cellular factors required for silencing of the bgl promoter using DNA affinity
chromatography (results section 1). Proteins specifically binding to the bgl upstream
silencer and promoter region, as found from this experiment, included only H-NS.
This confirmed the role of H-NS in bgl promoter silencing via direct binding to the
bgl DNA fragment used. However, no other proteins could be identified which played
a similar role. As discussed in the results section 1, this may have been a limitation of
the biochemical approach used. Alternatively, as substantiated from further results,
only H-NS may bind to the upstream bgl silencer and the bgl promoter DNA, causing
transcriptional repression. The requirement of additional factors for bgl silencing
proposed earlier (Schnetz, 1995) might have to do with regulation of the bgl operon at
other physical locations like the downstream silencer and at different levels eg at post-
transcriptional level.
3. Amplification of bgl silencing and activation by BglG cellular threshold at
low expression levels.
The downstream bgl silencer region consists of the non-coding, bgl leader
sequence and the bglG gene sequence. The most prominent feature of the leader
sequence is the transcriptional terminator t1. As described in results section 2, unlike
on plasmids, the bgl operon could not be highly activated when present on the
chromosome, by the promoter de-repressing mutations. On a high copy plasmid, such
mutations resulted in upto 200-fold activation whereas when the same bgl constructs
were present on the chromosome the activation was only upto two folds. This
observation implied that a reduction in the copy number from the plasmidic to the
chromosomal system was responsible for this phenomenon. It was possible that this
maybe due to a titration effect on a negative regulatory factor, which became limiting
when the bgl operon was plasmid encoded. Alternatively, a positive regulatory factor,
which has to be encoded by the bgl operon itself, could become limiting due to low
expression levels when encoded on the chromosome. The obvious candidate for the
latter possibility was the positive regulator and antiterminator protein BglG. To test
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this possibility, extra BglG was provided in trans to a chromosomal de-repressed bgl
promoter construct causing increased activation upto 60 fold (results section 2.4).
Thus, high cellular levels of BglG protein, which could be achieved in the plasmidic
system but not from a chromosomal construct, were required for high expression of an
activated bgl operon. Thus BglG is limiting to bgl operon expression when the
transcription rate remains below a threshold, but not when the operon is transcribed at
higher levels. High expression levels are obtained (a) when additional BglG protein is
provided in trans, (b) when the expression is rendered BglG-independent by mutation
of the terminator, or (c) when the copy number is increased (from a chromosomal to a
plasmidic system). Interestingly, this threshold level of BglG required for high
expression could be reached even in a chromosomal system by a small further
activation of the promoter.
A model is shown in figure 22. Basal level of transcription that is initiated at
the repressed bgl promoter mostly terminates in the leader at terminator bgl-t1 (Fig.
22, left) (Mahadevan and Wright, 1987; Schnetz and Rak, 1988). If basal amounts of
bglG-mRNA that are transcribed due to the inherent leakiness of terminator bgl-t1 are
insufficient to allow synthesis of enough BglG protein for antitermination then the
expression remains low (Fig. 22, left). If the transcription rate is higher the basal BglG
amounts may exceed a threshold that allows antitermination (Fig. 22, right). Once
antitermination occurs, BglG amounts increase and the remainder of the operon can
be expressed at high levels by antitermination at terminator t2. Possible mechanisms
leading to limitation of BglG may involve (a) inefficient activation of BglG by HPr
mediated phosphorylation (Görke and Rak, 1999) and dimerization (Amster-Choder
and Wright, 1992) at low cellular concentrations and/or (b) low efficiency of BglG
synthesis possibly due to instability of the bglG mRNA and the low translation
efficiency. Expression of BglG in trans or an increase in the copy number would
overcome these limitations and lead to full expression. In a rpoS mutation, the three
fold upregulation of the bgl promoter was sufficient to result in a sufficiently high
BglG expression, which in turn caused efficient antitermination resulting again in
higher BglG levels and so on (results section 2.6). The threshold of BglG required for
starting the expression amplification loop shown in figure 22 can amplify silencing or
activation of the operon. The leader (terminator t1) part of the downstream silencer,
thus contributes to the bgl operon regulation.
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4. Positive regulatory factors of the bgl operon expression.
A genetic mutation screen (results section 3) for genes required for high bgl
expression yielded three new candidate genes hfq, pgi and lon. Hfq is a known RNA
binding protein and has RNA chaperone activity. Although Hfq is essential for
translation of the rpoS mRNA, the positive effect of Hfq on bgl expression was
independent of RpoS. It was shown that the positive effect exerted by Hfq is at the
bglG gene sequence. It is conceivable that Hfq specifically binds to the bglG mRNA
and stabilizes it. Direct binding of Hfq to the bglG mRNA needs to be confirmed
experimentally. Recently it has been suggested that pgi mutation leads to a block in
the glycolytic pathway and catabolic utilization of glucose. This was also shown to
accelerate the RNaseE mediated degradation of ptsG mRNA. It was proposed that pgi
mutation could lead to a general response in which activities of various RNases are
upregulated resulting in specific downregulation of the genes whose mRNAs are
susceptible to the respective RNases (Kimata et al., 2001). The bgl operon could be
specifically downregulated by such a response caused by the pgi mutation. It would
be interesting to further characterize this response and to determine if the genes
downregulated by it belong to a particular functional category.
The lon gene mutation also caused downregulation of an activated bgl operon.
It is possible that Lon, which is a protease, specifically downregulates a bgl repressor
protein and thus in the absence of Lon, the repressor protein activity is higher causing
bgl downregulation. One possible candidate for such a repressor was StpA and Lon
could regulate bgl expression via StpA (Johansson and Uhlin, 1999). This possibility
could not be tested since the lon and stpA mutations could not be combined using
phage mediated transductions. In such double mutants, the levels of cell division
inhibitor SulA, which is degraded by Lon, are perhaps too high and cause a lethal
phenotype. It was possible to combine the lon and stpA mutations in a sulA
background showing that the positive effect of Lon on bgl expression is independent
of StpA (Klingen and Schnetz, unpublished results). Thus, precise mechanism of the
Lon effect remains to be determined.
The genetic mutation screen for genes required for silencing of the bgl operon
yielded only hns mutants (results section 3) thus supporting the hypothesis that H-NS
is the dominant negative regulator of the bgl operon. Other possible negative
regulators may not exist or these factors are non-redundant and mutation of the
respective gene may cause a lethal phenotype. It is also possible that the effects of
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some of the negative regulatory factors, direct or indirect, are smaller compared to
that of H-NS and may escape detection in the mutagenesis screen eg the negative
effect of RpoS on bgl expression can remain unobserved until the antiterminator BglG
level threshold is crossed.
5. Regulation of the bgl mRNA stability.
It was shown that H-NS downregulates the bgl expression via the downstream
silencer even in the absence of the upstream silencer sequences (results section 4).
This downstream effect of H-NS was upto 14 fold and was more than the known role
of H-NS i.e. binding to the upstream silencer sequences and repression of the bgl
promoter (upto 4 fold, in the absence of the downstream silencer). The downstream
effect of H-NS was dependent on the bglG sequence and it was shown that in a hns
mutant the mRNA half life of the bglG part of the bgl mRNA (measured at three
different locations along the bglG sequence) was approximately 2 fold higher
compared to that in a wt strain. However, hns mutation did not affect the stability of
the bgl leader mRNA (results section 4.2). It remains to be determined whether H-NS
can directly bind to the bgl mRNA and decrease its stability or whether it is an
indirect effect.
At this point an interesting picture of the bgl regulation via the downstream
silencer sequence emerges. First of all, the terminator t1 prevents transcriptional
readthrough unless the cellular levels of antiterminator BglG are sufficiently high.
Even when there is efficient antitermination, the bglG mRNA is destabilized in the
presence of H-NS. Indeed, this post-transcriptional role of H-NS is more prominent
than its previously known role, namely, transcriptional silencing of the bgl promoter
via the upstream silencer. Two more genes pgi and hfq possibly play a role in
regulation of the bgl mRNA stability. Thus, post-transcriptional regulation of the bgl
expression by alteration of the mRNA stability emerges as a prominent level of bgl
regulation. The roles of H-NS, Hfq and Pgi in such a system need to be further
analyzed. It is necessary to determine whether some of these proteins can directly
bind to the bgl mRNA thus possibly changing its structure and/or susceptibility to the
RNA degrading machinery. It will also be interesting to determine exactly which
components of the RNA degradosome are specifically involved in bgl mRNA
degradation. It is possible that H-NS, a negative regulator of the bgl mRNA stability
and Hfq which presumably regulates it positively, act as antagonists. The RNA
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protective role played by the translating ribosomes is also important. It is the changes
in relative levels of these, which may decide the bgl mRNA stability and the operon
activity. The pgi mutation may also feed in to this system indirectly by influencing
activities of the various RNA degradosome components.
What kind of environmental or other conditions may change the relative levels
of these factors leading to activation of the wt bgl operon? Activation of the wt bgl
operon in a pathogenic E. coli strain in vivo (in the host) may be caused by such a
change in the relative levels of various pleiotropic regulators (Khan and Isaacson,
1998).
Furthermore, it is possible that there are factors/proteins binding directly to the
downstream silencer DNA causing transcriptional downregulation. It has been shown
that H-NS does not specifically bind to the leader or bglG DNA (Wahle and Schnetz,
unpublished results). However downregulation of transcription elongation via
secondary structure formation can not be ruled out.
One of the important questions that remains to be answered is the significance
and mechanism of evolutionary maintenance of the silent bgl operon. It has been
suggested that the bgl operon is kept silent in order to avoid the effects of certain toxic
b-glucosides present in nature (Reynolds et al., 1981). It is possible that the wt bgl
operon is expressed under certain environmental conditions eg those found inside a
host (Khan and Isaacson, 1998). However this possibility needs further examination.
Otherwise, there are no known in vitro (outside the host) conditions which result in
activation of the bgl operon. In the current work no specific regulators of the bgl
operon expression were found. Proteins like H-NS, StpA, Hfq, RpoS and Lon are non-
specific or pleiotropic regulators of E. coli gene regulation. It is possible that under
certain environmental conditions, yet unknown, the relative levels of these regulators
change in such a way as to allow expression of the bgl operon considering the
amplification in the bgl operon activity by the requirement of cellular threshold of the
antiterminator BglG.
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V. Materials and methods
1. Chemicals, enzymes and other materials
Chemicals and enzymes were purchased unless otherwise specified from commercial
sources. Oligonucleotides were purchased from Eurogentec or Invitrogen life
technologies.
2. Media and agar plates
LB2Y medium (1l) 10g Bacto Tryptone (Difco)
10g Yeast Extract (Difco)
5g NaCl
(for plates 15g Bacto Agar, Difco)
NB medium (1l) 8g Bacto NB broth, dehydrated (Difco)
(3g Bacto Beef extract, 5g Bacto peptone)
MacConkey lactose 40g MacConkey Agar (Difco)
indicator plates (1l) 10g Lactose
BTB salicin 15g Bacto Agar (Difco)
indicator plates  1g  Yeast-Extract (Difco)
(Schaefler, 1967) 1g  Tryptone (Difco)
 5g  NaCl
add 900ml H2O, autoclave
add sterile:
1ml  1M MgSO4
1ml  0.1M CaCl2
1ml  Vitamin B1 (stock solution 1mg/ml, filter
sterilized)
0.5ml  FeCl3 1mM
20ml  10% (w/v) Casaminoacids
50ml sugar ( 10% Salicin)
10ml bromthymol blue stock solution (2% BTB in
50% Ethanol, 0.1N NaOH)
M9 Medium          20 x M9:140g Na2HPO4 x 2 H2O
(Miller, 1972) 60g KH2PO4
20g NH4Cl
H2O to 1l
M9 Medium (prepare from sterile solutions):
20 x M9 50ml
    0.1M CaCl2 1ml
1 M MgSO4 1ml
1mM FeCl3 0.5ml
            carbon source 1% final concentration:
20% Glucose 50ml
or 80% Glycerin 12.5ml
if required:
1mg/ml Vitamin B1 1ml
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10% casamino acids 66ml
H2O  final volume 1l
Antibiotics were added to the final concentrations as shown below
ampicillin stock 50mg/ml in 50% ethanol final conc. 50mg/ml
chloramphenicol stock 30mg/ml in ethanol final conc. 15 mg/ml
kanamycin stock 10mg/ml in H2O final conc. 25 mg/ml
rifampicin stock 100mg/ml in methanol final conc. 100 mg/ml
spectinomycin stock 50mg/ml in 30% ethanol final conc. 50µg/ml
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Table 1: Synthetic oligonucleotides used in the present work
namea sequenceb descriptionc
S6 AACCCGACTTCACCAGTATTC bgl: +554 to +534
S83 CCGCTCGA GGATCCTCTGTTACAGGTCACTAATACCATCTAA lambda attP
S84 CCGGTCGACAGATCTGAAATCAAATAATGATTTTATTTTGACTG lambda attP
S92 CAAGAGGAATATGACTTAAGAGTTCG bgl: +792 to +757
S100 CATCGTAACCGTGCATCTGCCA lac: +330 to +309
S107 GGATCTTCACCTAGATCCTTTTGGTCGA pFDX733: 8632 to
8651
S123 TGTGGAATTGTGAGCGGATA sequencing primer -
tacOP
S125 P-GGATAAACTGCTGGCGGG bgl: +260 to +277
S127 P-CATGATTACGGATTCACTGGCCGT lac: +67 to +44
S140 P-GTTAUGTCAGGTTTTGCCTGCGAA bgl: +9 to +56
S141 P-CATCUGCCAGTTTGAGGGGACGACGA lac: +317 to +292
S156 GATGATAAAAGGCACCTTTGGTCA MiniTn10 primer
S172 CCGAAGCTTGAATTCGCATATAAGGAAAAGAGAGAATGGCTA miaA/hfq
S174 GCGC GTCGACAGGCTTTACACTTTATGCTT PlacUV5:-41 to -21
S175 TCCAGGTTCGTCCACACATTATACGAGCCGGAA PlacUV5: +1 to –22
S176 AATGTGTGGACGAACCTGGATGTTCGTTATAA         PlacUV5:-10 region
bgl: +1 to +22
S184 ATAACCAGAGAATACTGGTGAACAGGGGTTTTTTTGTTTATAAAA bgl: +75 to +119
S185 TTCACCAGTATTCTCTGGTTATCAGAGGTTTTGCCTGCGAATGCA bgl: +96 to +51
S186 ATAACCAGAGAATACTGGTGAAGTCGGGT bgl: +75 to +103
S187 TTCACCAGTATTCTCTGGTTATGTCAGGTT bgl: +96 to +67
S188 CCTGACATAACCAGAGAATACTGGTGAAGTCGGTTTTTTTGTTTA bgl: +69 to +113
S189 P-GCAAAGAACACATGACCATGATTACGGATTCACTGGCCGT bgl: +955 to +965
lac: +39 to +67
S190 AATCTAGA GCAAGGACCTTTTTTATAAACAA bgl: +131 to +108
S204 AATCTAGA TTAGATTTGCATGTTCATAGCAAGGA bgl: +146 to +124
S205 ATGAACATGCAAATCATGACCATGATTACGGATTCA bgl: +132 to +146
lac: +39 to +59
S206 GATTTGCATGTTCATAGCAAGGACCTT bgl: +146 to +120
S207 AATCTAGA TTACACCACAACATTATTGTTGAGAA bgl: +176 to +154
S208 CACCACAACATTATTGTTGAGAA bgl: +176 to +154
S209 CTCAACAATAATGTTGTGGTGATGACCATGATTACGGATTCA bgl: +156 to +176
lac: +39 to +59
S215 TTCCGGCTCGTATAATGTGTGGAAGTCGGGTTTTTTTGTTTATAAAAA
AGGT
bgl: +95 to +124
S220 GCGGATCCATGAACATGCAAATCACCAAAATTCTCA              bgl: +132 to +159
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Table 1: Synthetic oligonucleotides used in the present work
namea sequenceb descriptionc
S221 AAGCTAGCCAATTCCGCGCCCCATGACGA         bgl: +226 to +205
S222 GGGGATCCTGGGATATCCAGCGGCTTTACCCGA bgl: +492 to +516
S223 TTGCTAGCTGGCAATAAAGCCCACTTCATCTTTCGGTA bgl: +606 to +577
S224 GGGGATCCACCCGCAAGCATGGCAATGT bgl: +841 to +860
S225 TTGCTAGCGTGTTCTTTGCGCACGCGCTCTA bgl: +965 to +943
S251 AAGCTAGCAGCAAGGACCTTTTTTATAAACAAAAAAACCCGA bgl: +131 to +98
a: Name of the oligo in lab collection
b: Sequence is shown from 5' to 3' end. P indicates 5' phosphate, U indicates biotinylated Uridine,
restriction enzyme sites are underlined, bgl sequences are in italics.
c: Wherever relevant bgl and lac operon homologies are indicated. Numbering relative to transcription
start of the respective operon. Additional descriptions and strategies when used for cloning are
documented in lab records.
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Table 2: E. coli K-12 strains used in the present work
strain relevant genotype or structurea constructionb / reference
W3110 l- F- bgl° IN(rrnD-rrnE) (=CGSC#4474) (=S48) (Bachmann, 1996)
CSH50 bgl° D(lac-pro) ara thi (=S49) (Miller, 1972)
PD32 MC4100 hns-206::ApR strR (=S102) (Dersch et al., 1993)
R1243 CSH50 bgl::IS1-R1243 (Bgl+) (=S157) (Schnetz and Rak, 1992)
S162 CSH50 Dbgl-AC11 (Caramel and Schnetz, 1998)
S228 CSH50 DbglGFBHIK-AC11 DlacZ-Y217 pro+ lab collection
S278 S162 Dbgl-AC11 D(argF-lac)U169 Pro+ x T4GT7(MC4100), lab collection
S387 S228  attB::[SpecR wtPbgl +54-bglG-lacZ] x pKES15, lab collection
S393 S228  attB::[SpecR D2Pbgl +54-bglG-lacZ] x pKES18, lab collection
S397 S228  attB::[SpecR wtPbgl +54-orfG-lacZ] x pKES20, lab collection
S403 S228  attB::[SpecR D2Pbgl +54-orfG-lacZ] x pKES23, lab collection
S484 CSH50 bgl° D(argF-lac)U169 Pro+ x T4GT7(MC4100) , lab
collection
S486 S484 bgl° (gpt-lac)+ Lac+ x T4GT7(W3110) , lab collection
S524 S486 DlacZ-Y217 lab collection
S539 S278 Dbgl-AC11 (gpt-lac)+ Lac+ x T4GT7(W3110)
S541 S539 Dbgl-AC11 DlacZ-Y217 lab collection
S544 bgl-CRP DlacZ-Y217 Bgl+ mutant of S524
S572 CSH50 (pro-lac)+ bglR::C234 (CAP-site mutant) x T4GT7(S48)
S581 S486 bgl° DlacOP::(specR wtPbgl +55-orfG) x pKES44 (Dabert and Smith,
1997)
S594 S572 bgl-CAP+-C234  DlacOP::(specR CAP+-C234 Pbgl
+55-orfG)
x pKES51 (Dabert and Smith,
1997)
S614 S541 hns::ApR x T4GT7(PD32)
S749 S594 lon108 results section 3,  figure 13
S750 S594 hfq110 results section 3,  figure 13
S751 S594 pgi111 results section 3
S752 S594 pgi112 results section 3
S753 S594 pgi123 results section 3
S754 S594 lon124 results section 3,  figure 13
S755 S594 pgi132 results section 3
S756 S594 cyaA152 results section 3
S757 S594 hfq155 results section 3,  figure 13
S759 S594 lon166 results section 3,  figure 13
S760 S594 lon172 results section 3,  figure 13
S762 S594 lon183 results section 3,  figure 13
S763 S594 hfq184 results section 3,  figure 13
S764 S594 lon187 results section 3,  figure 13
S765 S594 pgi194 results section 3
S766 S594 lon204 results section 3,  figure 13
S770 S541 pgi111 x T4GT7(S751)
S772 S541 hfq155 x T4GT7(S757)
S776 S541 lon187 x T4GT7(S764)
S777 S541 pgi194 x T4GT7(S765)
S778 S539 hfq155 x T4GT7(S772)
S790 S387 hfq155 x T4GT7(S772)
S792 S393 hfq155 x T4GT7(S772)
S794 S539 lon187 x T4GT7(S776)
RH90 MC4100 rpoS359::Tn10  (=S810) (Lange and Hengge-Aronis, 1991)
MC4100 F- bgl° D(argF-lac)U169 araD139 deoC1
flb5301 relA1 rpsL150 ptsF25 rbsR (=S101)
(Casadaban, 1976)
AM111 MC4100 hfq1::W   (=S812) (Muffler et al. 1996)
AM112 MC4100 hfq2::W  (=S813) (Muffler et al. 1996)
S829 S387 hfq1::W  (KanR) x T4GT7(AM111)
S831 S393 hfq1::W  (KanR) x T4GT7(AM111)
S833 S397 hfq1::W  (KanR) x T4GT7(AM111)
S835 S403 hfq1::W   (KanR) x T4GT7(AM111)
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Table 2: E. coli K-12 strains used in the present work
strain relevant genotype or structurea constructionb / reference
S837 S387 hfq2::W  (KanR) x T4GT7(AM112)
S839 S393 hfq2::W  (KanR) x T4GT7(AM112)
S841 S397 hfq2::W  (KanR) x T4GT7(AM112)
S843 S403 hfq2::W  (KanR) x T4GT7(AM112)
S885 S541 hfq1::W  (KanR) x T4GT7(AM111)
S887 S541 rpoS359::Tn10 x T4GT7(RH90)
S891 S397 hfq155 x T4GT7(S772)
S893 S403 hfq155 x T4GT7(S772)
S940 S541 attB::[SpecR wtPbgl t1 bglG lacZ] x pKESD8
S942 S541 attB::[SpecR bgl-D2 Pbgl t1 bglG lacZ] x pKESD11
S944 S541 attB::[SpecR lacUV5 t1 bglG lacZ] x pKESD20
S960 S944 hfq1::W  (KanR) x T4GT7(AM111)
S1052 S541 attB::[SpecR bgl-CRP Pbgl t1 bglG lacZ] x pKESD9
S1054 S541 attB::[SpecR bgl::IS5-H3 Pbgl t1 bglG lacZ] x pKESD12
S1071 S524 rpoS359::Tn10 x T4GT7(RH90)
S1079 S544 rpoS359::Tn10 x T4GT7(RH90)
S1095 S541 attB::[SpecR lacUV5 t1 bglG lacZ] x pKESD20
S1097 S541 attB::[SpecR lacUV5 t1-L  bglG lacZ] x pKESD28
S1099 S541 attB::[SpecR lacUV5 t1-R bglG lacZ] x pKESD29
S1101 S541 attB::[SpecR lacUV5 t1-LR  bglG lacZ] x pKESD30
S1103 S541 attB::[SpecR lacUV5 t1-DG100 bglG lacZ] x pKESD31
S1107 S539 rpoS359::Tn10 x T4GT7(RH90)
S1112 S614 hfq1::W  (KanR) x T4GT7(AM111)
S1130 S1095 rpoS359::Tn10 x T4GT7(RH90)
S1132 S1097 rpoS359::Tn10 x T4GT7(RH90)
S1142 S541 attB::[SpecR wtPbgl t1-L bglG lacZ] x pKESK11
S1144 S541 attB::[SpecR bgl-CRPPbgl t1-L bglG lacZ] x pKESK12
S1146 S541 attB::[SpecR bgl-D2Pbgl t1-L bglG lacZ] x pKESK13
S1148 S541 attB::[SpecR bgl::IS5-H3Pbgl t1-L bglG lacZ] x pKESK14
S1155 S1142 rpoS359::Tn10 x T4GT7(RH90)
S1157 S1144 rpoS359::Tn10 x T4GT7(RH90)
S1159 S1146 rpoS359::Tn10 x T4GT7(RH90)
S1161 S1148 rpoS359::Tn10 x T4GT7(RH90)
S1189 S541 attB::[SpecR lacUV5 t1-L orfG lacZ] x pKESD47
S1191 S541 attB::[SpecR lacUV5 t1-L RBS-bglG-RBS-lacZ
lacZ]
x pKESD36
S1211 S541 attB::[SpecR Pbgl(-76 to +25) lacZ] x pKEKB25
S1213 S541 attB::[SpecR wtPbgl+25 lacZ] x pKEKB30
S1215 S541 attB::[SpecR bgl-CRPPbgl+25 lacZ] x pKEYK01
S1217 S541 attB::[SpecR bgl-CRPPbgl(-76 to +25) lacZ] x pKEYK02
S1245 S541 bgl::IS1-R1243 [Bgl+] x T4GT7(R1243)
S1250 S887 bgl::IS1-R1243 [Bgl+] rpoS359::Tn10 x T4GT7(R1243)
S1252 S1189 hns:: ampR x T4GT7(PD32)
S1254 S1191 hns:: ampR x T4GT7(PD32)
S1307 S944 hns:: ampR x T4GT7(PD32)
S1309 S1097 hns:: ampR x T4GT7(PD32)
S1311 S1097 hfq1::W  (KanR) x T4GT7(AM111)
S1365 S541 attB::[SpecR bgl::IS5-H3  bglGFB] x pKESD63
S1367 S541 attB::[SpecR bgl-D2 bglGFB] x pKESD64
S1384 S1365 rpoS359::Tn10 x T4GT7(RH90)
S1386 S1367 rpoS359::Tn10 x T4GT7(RH90)
S1402 S1142 hfq1::W  (KanR) x T4GT7(AM111)
S1404 S1155 hfq1::W  (KanR) x T4GT7(AM111)
S1406 S1146 hfq1::W  (KanR) x T4GT7(AM111)
S1408 S1159 hfq1::W  (KanR) x T4GT7(AM111)
S1410 S1148 hfq1::W  (KanR) x T4GT7(AM111)
S1412 S1161 hfq1::W  (KanR) x T4GT7(AM111)
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Table 2: E. coli K-12 strains used in the present work
strain relevant genotype or structurea constructionb / reference
S1414 S964 hfq1::W  (KanR) x T4GT7(AM111)
S1416 S1132 hfq1::W  (KanR) x T4GT7(AM111)
S1418 S539 hfq1::W  (KanR) x T4GT7(AM111)
S1420 S1107 hfq1::W  (KanR) x T4GT7(AM111)
S1422 S539 pgi111 x T4GT7(S770)
S1424 S539 pgi194 x T4GT7(S777)
S1467 S1142 hns::ApR x T4GT7(PD32)
S1469 S1146 hns::ApR x T4GT7(PD32)
S1471 S1213 hns::ApR x T4GT7(PD32)
S1473 S1211 hns::ApR x T4GT7(PD32)
S1475 S1215 hns::ApR x T4GT7(PD32)
S1477 S1217 hns::ApR x T4GT7(PD32)
a:  The relevant genotype of the constructed CSH50 derivatives refers to the bgl, lac, hfq, lon, pgi,
cyaA, hns and rpoS loci. Mutations causing activation of the silent bgl operon include bgl-CRP (a C to
T exchange in the CRP binding site at position –66, relative to the transcription start), bgl::IS1-R1243
(integration of IS1 in orientation II generating a target site duplication from -88 to -80), bgl::IS5-H3  (an
integration of IS5 in orientation II generating a target site duplication from position –92 to –89), and
bgl-D2 (a deletion of the upstream silencer, extending from position –77). For terminator mutations t1-
L, t1-R, t1-LR, and DG100 see figure 9. (Strain numbers in brackets refer to lab-stocks.)
b:  Transductants (using T4GT7) of Bgl+ alleles were selected on minimal Salicin B1 plates, of
rpoS359 ::Tn10 on LB tetracycline plates, on minimal glucose B1 plates (Pro+), or on minimal lactose
plates (Lac+). Integrations in to attB were performed as described(see material and methods).
(Diederich et al., 1992)
                         Materials and Methods                            54
Table 3: Plasmids used in the present work
name relevant structure/descriptiona and
replicon/resistanceb
source/constructionc/ reference
pLDR8 lambda repressor, temperature sensitive
allele cI-857; int under control of l PR,
pSC101 rep-ts, kan
(Diederich et al., 1992)
pFDX733 wt bgl operon, kan (Schnetz et al., 1987)
pFDX733-
C234
bgl-C234 allele of bgl operon, kan Lab collection
pFDX733-
H3
IS5-H3 allele of bgl operon, kan Lab collection
pFDY167 wt-Pbgl t1 bglG lacZ, kan Lab collection
pFDY167-
H3
IS5-H3-Pbgl t1 bglG lacZ, kan Lab collection
pFDY217 lacI lacOP lacY, pSC101 rep-ts, tet Lab collection
pFDY241 lacUV5 t1 bglGFB, kan Lab collection
pFDY446 bgl-D2 allele of bgl operon, kan Lab collection
pFDY558 C234-Pbgl t1 bglG lacZ, kan Lab collection
pFDY560 D2-Pbgl t1 bglG lacZ, kan Lab collection
pHP45
omegon
aadA bla T4-t32a terminator, pBR (Prentki and Krisch, 1984)
pKEKB25 attP Pbgl (bgl: –76 to +25) lacZ Lab collection
pKEKB30 attP wt-Pbgl+25 lacZ Lab collection
pKES15 attP wt-Pbgl+54 lacZ Lab collection
pKES18 attP D2-Pbgl+54 lacZ Lab collection
pKES20 attP wt-Pbgl+54 orfG lacZ Lab collection
pKES23 attP D2-Pbgl+54 orfG lacZ Lab collection
pKES44 chi lacI-q wt-Pbgl+54 lacZ chi Lab collection
pKES51 chi lacI-q C234-Pbgl+54 orfG lacZ chi Lab collection
pKESD7 attP wt-Pbgl bglG lacZ, kan V: pFDY167-SalI, phosphatase
F: Lambda attP PCR S83/S84, XhoI/Sal I
pKESD8 attP wt-Pbgl bglG lacZ V: pKESD07 BglII, phosphatase
F: pHP45Omegon BamHI (2056bp fragment
containing spc/str res gene aadA)
pKESD9 attP C234-Pbgl bglG lacZ V: pKESD08 SalI/XhoI
F: pFDY558 SalI/XhoI
pKESD11 attP D2-Pbgl bglG lacZ V: pKESD08 SalI/XhoI
F: pFDY560 SalI/XhoI
pKESD12 attP IS5-H3-Pbgl bglG lacZ V: pKESD08 SalI/XhoI
F: pFDY167-H3 SalI/XhoI
pKESD20 attP lacUV5 t1 bglG lacZ V: pKESD08 salI/AflII,phosphatase
F: PCR template pFDY241 S174/S175, PCR
template pKESD8 S176/S92, PCR template
products 1+2 S174/S92, SalI/AflII
pKESD24 attP lacUV5  t1-L   lacZ (translational
fusion in to bglG-ATG)
V: pKESD23 SalI/Eco81I, phosphatase
F: PCR template pFDX733 S174/S185, PCR
template pFDX733 S186/S100, PCR template
products1+2 S174/S100, SalI/Eco81I
pKESD28 attP lacUV5  t1-L  bglG  lacZ V: pKESD20 SalI/AflIII, phosphatase
F: PCR template pFDX733 S174/S185, PCR
template pFDX733 S186/S100, PCR template
products 1+2 S174/S92, SalI/AflII
pKESD29 attP lacUV5  t1-R  bglG  lacZ V: pKESD20 SalI/AflIII, phosphatase
F: PCR template pFDX733 S174/S187, PCR
template pFDX733 S184/S100,
 PCR template products 1+2 S174/S92,
SalI/AflII
                         Materials and Methods                            55
Table 3: Plasmids used in the present work
name relevant structure/descriptiona and
replicon/resistanceb
source/constructionc/ reference
pKESD30 attP lacUV5  t1-LR  bglG  lacZ V: pKESD20 SalI/AflIII, phosphatase
F: PCR template pFDX733 S174/S185, PCR
template pFDX733 S184/S100, PCR template
products 1+2 S174/S92 SalI/AflII
pKESD31 attP lacUV5  t1-DG100  bglG  lacZ V: pKESD20 SalI/AflIII, phosphatase
F: PCR template pFDX733 S174/S187, PCR
template pFDX733 S188/S100, PCR template
products 1+2 S174/S92 SalI/Eco81I
pKESD36 attP lacUV5  t1-L +130  lacZ V: pKES15 XbaI/SalI, phosphatase
F: PCR template pKESD28 S94/S190
SalI/XbaI
pKESD39 attP lacUV5  t1-L F(bglG 278aa-lacZ) V: pKESD28 Eco81I/FspI, phosphatase
F: PCR template pFDX232 S189/S100 Eco81I
pKESD42 attP lacUV5  t1-L bglG (5aa) lacZ V: pKES15 SalI/XbaI, phosphatase
F: PCR template pKESD28 S94/S204
SalI/XbaI
pKESD43 attP lacUV5  t1-L F(bglG 5aa-lacZ) V: pKESD28 SalI/Eco81I, phosphatase
F: PCR template pKESD28  S94/S206, PCR
template pKESD28 S205/S100, PCR template
products 1+2  S94/S100 SalI/Eco81I
pKESD44 attP lacUV5  t1-L bglG (15aa) lacZ V: pKES15 with SalI/XbaI, phosphatase
F: PCR template pKESD28 S94/S207,
SalI/XbaI
pKESD45 attP lacUV5  t1-L F(bglG 15aa-lacZ) V: pKESD28 SalI/Eco81I, phosphatase
F: PCR template pKESD28 S94/S208, PCR
template pKESD28 S209/S100, PCR template
products 1+2 S94/S100, SalI/Eco81I
pKESD47 attP lacUV5  t1-L orfG lacZ V: pKESD28 salI/AflII phosphatase,
F: PCR template pKESD28 S92/S185,
PCR template pFDY487S186/S92, PCR
template products 1+2 S92/S94, SalI/AflII
pKESD48 attP lacUV5 +95  bglG  lacZ V: pKESD28 SalI/AflII, phosphatase
F: PCR template pKESD28 S94/S214,
PCR template pKESD28 S215/S92,
PCR template products 1+2 S94/S92,
SalI/AflII
pKESD49 attP lacUV5 +95  orfG  lacZ V: pKESD28 SalI/AflII, phosphatase
F: PCR template pKESD28 S94/S214,
PCR template pKESD47 S215/S92, PCR
template products 1+2 S94/S92, SalI/AflII
pKESD53 lacI Ptac bglG gene fragment ( bglG nt 1-
95) rrnB-T1,T2 , pBR, amp
V: pFDY157 BamHI/Nhe1, phosphatase
F: PCR template pFDX733 S220/S221,
BamHI/NheI
pKESD54 lacI Ptac bglG gene fragment (bglG
nt361-475) rrnB-T1,T2 , pBR, amp
V: pFDY157 BamHI/Nhe1, phosphatase
F: PCR template pFDX733 S222/S223,
BamHI/NheI
pKESD55 lacI Ptac bglG gene fragment(bglG
nt709-834) rrnBT1/T2 , pBR, amp
V: pFDY157 BamHI/Nhe1, phosphatase
F: PCR template pFDX733 S224/S225,
BamHI/NheI
pKESD62  IS1-Pbgl  t1 bglGFB, kan V: pFDX733 SalI/AflII, phosphatase
F: PCR template genomic DNA strain S157
S107/S92, SalI/AflII
pKESD63 attP IS5-H3-Pbgl t1 bglGFB V: pKESD08 SalI/XhoI, phosphatase
F: pFDX733-H3 SalI/XhoI
pKESD64 attP D2-Pbgl t1 bglGFB V: pKESD08 SalI/XhoI, phosphatase F:
pFDY446 SalI/XhoI
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Table 3: Plasmids used in the present work
name relevant structure/descriptiona and
replicon/resistanceb
source/constructionc/ reference
pKESD65 lacI Ptac lacO bgl:+1-131 t1-L, pBR,
amp
V: pFDY157 BamHI/NheI, phosphatase
F: PCR template pKESD46 S123/S251,
BamHI/NheI
pKESK10 lacI lacUV5 lacO bglG, pSC101,cm Lab collection
pKESK11 wt-Pbgl  t1-L bglG lacZ Lab collection
pKESK12 C234-Pbgl  t1-L bglG lacZ Lab collection
pKESK13 D2-Pbgl  t1-L bglG lacZ Lab collection
pKESK14 IS5-H3-Pbgl  t1-L bglG lacZ Lab collection
pKEYK01 attP C234-Pbgl+25 lacZ Lab collection
pKEYK02 attP C234-Pbgl (-76 to +25) lacZ Lab collection
a: The relevant genotype is shown. Mutations causing activation of the silent bgl operon include bgl-
C234 (a C to T exchange in the CRP binding site at position –66, relative to the transcription start),
bgl::IS1-R1243 (integration of IS1 in orientation II generating a target site duplication from -88 to -80),
bgl::IS5-H3-H3  (an integration of IS5 in orientation II generating a target site duplication from position
–92 to –89), and bgl-D2 (a deletion of the upstream silencer, extending from position –77). For
terminator mutations t1-L, t1-R, t1-LR, and DG100 see figure 9.
b: Plasmids when not stated carried pACYC (pA15) replication origin (Chang and Cohen, 1978) and
kanamycin (kan), spectinomycin resistance markers. Those carrying pSC101 replication origin
(Hashimotoh-Gotoh et al., 1981) or pBR replication origin (Bolivar, 1978) and chloramphenicol (cm)
or tetracyclin (tet) resistance markers are indicated.
c: This table gives a short description of the plasmid construction. The first line (V:) indicates the
vector fragment. The second line (F:) indicates the insert fragment preparation. PCR reactions are
indicated in the order; PCR, template DNA and primers used. For further details see methods. Detailed
plasmid construction descriptions are documented in lab records and all sequences are compiled in
Vector NTi. All the PCR fragments cloned were verified for absence of PCR introduced errors by
sequencing.
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3. General Methods
The molecular biology methods like restriction and other enzyme reactions, PCR,
plasmid DNA purification, SDS-PAGE chromatography, sequencing gels and
auto-radiography were performed as described (Sambrook et al., 1989) or according
to the manufacturer's instructions, unless otherwise stated. Large scale preparation of
plasmid DNA were performed using the plasmid maxi kit (Qiagen) according to
manufacturers instructions.
4. TNE-method (Serghini et al., 1989)
Isolation of plasmid DNA for analytical purposes was performed according to the
TNE method
TNE buffer: 10mM Tris-HCl, pH 8.0
1mM EDTA, pH 8.0
100mM NaCl
- centrifuge 1.5ml of an overnight culture for 2 minutes 13000 rpm
- decant the supernatant, re-suspend the pellet in 100ml TNE buffer
- add 1 volume of Phenol-Chloroform-isoamyl alcohol, vortex very briefly (1-2
seconds)
- centrifuge for 5 minutes at 13000 rpm
- transfer the upper aqueous phase in to a new tube
- precipitate DNA with 2.5 volumes 100% ethanol, mix by inverting the tube
- centrifuge for 10 minutes at 13000 rpm
- wash the pellet with 80% ethanol
- centrifuge for 5 minutes at 13000 rpm
- decant the supernatant and dry the pellet under vacuum
- dissolve DNA pellet in 50ml H2O
- for restriction enzyme analysis use 8µl (low copy plasmids) and 2µl (high
copy plasmids), add RNase before loading DNA on to agarose gel
- store plasmid DNA at 4°C or -20°C
5. Plasmid isolation using CsCl2 gradient method (for pure supercoiled plasmid
DNA preparation)
buffer P1: 50mM Tris-HCl, pH 8.0
10mM EDTA pH 8.0
buffer P2: 0.2N NaOH
1% SDS (w/v)
buffer P3: 3M potassium-acetate, pH 5.5
CsCl/TE/Ethidium-bromide stock: 1:1:1/20 (eg 50g CsCl, 50ml TE, 2.5ml
            Ethidium-bromide 10mg/ml)
Butanol (H2O/CsCl saturated)
- grow 800ml over night culture
- centrifuge the overnight culture: eg J6-Beckman-centrifuge at 4200 rpm for 20
minutes,  4°C
- resuspend bacterial pellet in buffer P1, use 10ml per 100ml culture
- incubate for 5 minutes at room temperature
- add buffer P2 (10ml/100ml culture volume), mix gently, incubate for 5
minutes on ice
- add buffer P3 (10ml/100ml culture volume), mix thoroughly with a pipette,
incubate for at least 5 minutes
                         Materials and Methods                            58
- centrifuge for 15-20 minutes at 10000rpm, 4°C, eg GSA/Sorvall
- filter the supernatant to remove particles
- precipitate DNA by adding 0.7 volume isopropanol
- centrifuge for 15 minutes at 10000 rpm and 4°C
- air-dry the pellet
- re-dissolve the pellet in 3-4ml TE-buffer, pH8.0
- add CsCl to DNA / TE solution (1.1g CsCl per ml DNA solution), dissolve
CsCl carefully, clear turbid solutions by centrifugation
- add  Ethidium-bromide  (10mg/ml stock, 50µl per 1ml DNA solution)
- ultra centrifuge, eg 4h using Beckman TLN100 rotor, 100,000rpm
- recover supercoiled plasmid band with a syringe
- run a second gradient (fill up centrifuge tube with CsCl/TE/Ethidium-bromide
stock
- recover supercoiled plasmid DNA band with a syringe
- extract several times with Butanol (H2O/CsCl saturated) to remove Ethidium-
bromide (till solution is colorless and one additional time)
- precipitate DNA by adding 4 volumes 50% iso-propanol
- wash DNA pellet with 80% ethanol, dry pellet
- re-suspend DNA in 400µl TE (pH 8.0)
- measure OD260  (dilute the DNA, for example 1:50 or 1:100).
1 OD260 = 50µg/ml
6. Preparation of competent cells and transformation (CaCl2 method)
TEN buffer: 20mM Tris-Hcl pH 7.5, 1mM EDTA, 50mM NaCl
- grow cells in 50ml LB2Y medium till OD600=0.3
- centrifuge and resuspend the cell pellet in 25ml ice cold 0.1M CaCl2
- incubate on ice for 20 minutes
- centrifuge again and resuspend pellet in 2ml ice cold 0.1M CaCl2
- use 100ml of these cells for transformation
- add 10-50ng of the plasmid to be transformed in to 50ml of TEN buffer and
cool on ice.
- add 100ml of competent cells and incubate on ice for 20 minutes
- heat-shock at 42oC for exactly 2 minutes
- incubate on ice for 10 minutes
- add to 1ml LB2Y medium and shake at 37oC for 1 hour
- plate 100ml on suitable selective plates
7. Plasmids and DNA fragments
A brief description of plasmid constructions can be found in table 2. Details of
plasmid constructions are documented in the lab records and sequences compiled in
Vector NTi.
A series of plasmids starting with pKESD7 were constructed which have a pACYC
(p15A) replication origin (figure 23). They have the l phage attachment site, attP,
cloned in to them to allow for l integrase mediated recombinational insertion in to the
attB site of the E. coli chromosome (Diederich et al., 1992). These plasmids also have
a W cassette which contains the spectinomycin resistance gene, aadA and strong
transcriptional terminators at its 3' end. As seen in figure 23, plasmid pKESD8 has
convenient restriction enzyme sites which could be used to replace the bgl construct
with a different construct. For integration into the chromosomal attB site, all these
plasmids were then cut with BamHI and the originless fragment containing the
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spectinomycin resistance gene and the bgl construct was used for insertion in to the
attB site as described below.
8. Integration of plasmids in the attB site of E. coli chromosome (Diederich et al.,
1992)
- transform the recipient strain with helper plasmid pLDR8 and select on LB2Y
kanamycin plates at 28oC
- inoculate 3-4ml LB2Y kanamycin medium in glass tubes from a fresh single
colony of the strain/pLDR8-plates
- shake culture over night at 28°C
- inoculate 25ml LB2Y kanamycin medium in 100ml Erlenmeyer flask with
1.25ml (1:20 dilution) of the fresh over night culture
- shake culture at 37°C for 90minutes
- prepare competent cells using the CaCl2 method
- cut 5µg of the plasmid containing the construct to be integrated with BamHI
(10U) per 100µl over night at 37°C
- run on agarose gel and extract the originless fragment using Qiagen gel
extraction kit
- use 10ng BamHI-fragment for re-ligation in 20µl total volume
- transform the competent cells prepared as above using 10µl (=1/2) of BamHI
religation reaction
- plate: 2x 0.2ml on LB2Y spectinomycin plates and 1x 0.2ml on MacConkey
lactose spectinomycin plates
Figure 23: Schematic representation of plasmid pKESD8 . This plasmid and later plasmids based
on the same principle carry a l phage attachment site attP for integration in to the E. coli genome.
Resistance markers for spectinomycin (aadA) and kanamycin (neo) are shown. Plasmid pKESD8 has
a wtPbgl-bglG-lacZ construct. This contruct can be conveniently replaced with a different construct to
generate a series of plasmids used in this study. Some of the restriction sites which could be used for
this purpose are shown.
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- incubate plates at 42°C over night
testing of clones via PCR:
- pick a colony and resuspend the cells in 100µl H2O
- use the PCR-primer: S93/S164: to test the attB/P`-side
S95/S96: to test the attP/B`-side
S95/S164: to see integrations of dimers
suitable primers to test the fragment
9. Biochemical purification of bgl DNA binding proteins
Preparation of E. coli cell extracts (modified from Schnetz, 1995)
CE medium: 100mM potassium phosphate, pH 6.2, 10g/l yeast extract,
1mg/ml thiamine
extraction buffer: 12% Glycerol, 20mM Tris-HCl, pH 7.9, 2mM EDTA, 1mM
DTT
high salt lysis buffer: 12% Glycerol, 20mM Tris-HCl, pH 7.9, 1mM DTT, 1mM
PMSF, 700mM KCl
- prepare ovenight cultures in CE medium using a fresh colony
- inoculate 500ml CE medium using the overnight culture to a starting OD600 of
0.1.
- grow cultures with shaking at 370C till OD600 of 0.8
- put on ice and add 125ml pre-chilled 20mM Tris-Cl, pH 7.9
- centrifuge at 5000rpm, 20 minutes, 4°C
- wash with 50ml extraction buffer and centrifuge the cells again                                                                                                                                                                                            
- resuspend cells in 4.5ml high salt lysis buffer containing 1mg/ml Lysozyme
- incubate on ice with occassional swirling
- sonicate the cells on ice ( 2 x 10 second pulses)
- ultracentrifuge at 20000rpm for 30 minutes, 4oC (Beckman TLS 55 rotor)
- collect supernatant and add 10mM CaCl2 (final concentration)
- add Micrococcal nuclease (Roche) to 1000U/ml final concentration
- incubate at room temperature for 30 minutes
- add 50mM EGTA pH 8.0 solution to 2mM final concentration
- purify the protein solution over a PD10 column (Amersham Pharmacia
Biotech) using extraction buffer containing 2mM EDTA and 1mM PMSF for
equilibration of the column and for elution
- measure protein concentration using Bio-Rad protein assay kit, according to
manufacturer´s instructions
- aliquot protein solution, quick freeze in liquid N2 and store at –80°C
Phosphocellulose purification of cell extract
- dilute the cell extract prepared as above to 30mM KCl by adding extraction
buffer and 2.5M KCl
- wash activated phosphocellulose thrice with 3 volumes each of extraction
buffer containing 1M KCl. (1ml of phosphocellulose binds approximately 10-
60mg protein)
- equilibrate phosphocellulose thrice in 3 volumes of extraction buffer
containing 30mM KCl
- add cell lysate to phosphocellulose, allow binding for 30 minutes at 4°C, with
slow shaking
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- wash thrice in 3 volumes of extraction buffer containing 30mM KCl
- elute with 1 volume extraction buffer containing 800mM KCl
- repeat elution if necessary
- desalt eluted proteins with Nap5 column (Amersham Pharmacia Biotech)
- determine protein concentration using Bio-Rad protein assay kit, according to
manufacturer's instructions
DNA Affinity chromatography
B&W buffer: 5mM Tris-HCl, pH 7.5, 0.5mM EDTA, 1M NaCl
protein binding buffer:12% glycerol, 20mM Tris-HCl, pH7.9, 2mM EDTA,
1mM DTT, 100mM KCl
elution buffer: 12% glycerol, 20mM Tris-HCl, pH7.9, 2mM EDTA, 1mM
DTT, 700mM KCl
- prepare DNA fragments by PCR using Pwo polymerase (Roche Molecular
Biochemicals), plasmid pKESD08 as template, primer pairs S125/S140 (bgl)
and S127/S141(lacZ)
- purify the resulting PCR fragments using the PCR purification kit (Qiagen)
and concentrate if required by vaccum drying (Speedvac, Savant). Determine
final DNA concentration by measuring OD260
- use 100ml Streptavidin coated magnetic beads (10mg/ml) (Dynabeads M-280,
Dynal) per reaction. DNA binding capacity of the beads is 1pmol/mg
- at each of the following steps magnetically separate beads from the washing
buffer using the magnetic separator (Roche Molecular Biochemicals)
- remove supernatant and wash thrice with 100ml 1x B&W buffer
- add 25pmoles of respective DNA fragment in 1x B&W buffer (100ml) to the
beads and allow DNA binding by slowly rotating overnight at room
temperature.
- remove supernatant and wash thrice with 100ml 1x B&W buffer
- wash thrice with 100ml 1x protein binding buffer
- wash thrice with 100ml elution buffer
- wash thrice with 100ml 1x protein binding buffer
- add 100ml (50mg/100ml) protein solution in 1x protein binding buffer (for this
dilute the original cell extract with 5x protein binding buffer and distilled
water)
- incubate for 10 minutes at room temperature with slow rotation
- remove supernatant and wash thrice with 100ml 1x protein binding buffer
- perform the last washing in a fresh tube to avoid proteins bound to the tube
walls
- elute twice by incubating in 10ml elution buffer for 10 minutes each
- wash thrice with 100ml elution buffer
- wash thrice with 100ml 1x protein binding buffer
- beads with attached DNA fragments can now be reused for fresh protein
binding
- to the elutes (20ml) add equal volume of 12% trichloroacetic acid and incubate
on ice for 30 minutes
- centrifuge at 13000rpm, 4°C for 30 minutes
- wash with cold acetone (20ml) and re-centrifuge for 10 minutes
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- resuspend in SDS-PAGE loading dye and load on to 15% SDS-PAGE gel
(Sambrook et al., 1989)
Silver staining and protein identification
- fix gel in 50% methanol, 5% acetic acid for 20 minutes
- wash for 10 minutes in 50% methanol
- wash for 10 minutes in distilled water
- incubate in 0.02% Sodium thio-sulfate for 1minute
- rinse twice with distilled water
- put in chilled 0.1% silver nitrate, incubate for 20 minutes at 4°C
- rinse twice with distilled water
- add developer solution (0.04% formaldehyde, 2% Na2CO3), keep gently
shaking till bands develope sufficiently. If required replace the colored
developer solution with fresh solution
- stop the reaction with 5% acetic acid
- store in 1% acetic acid solution at 4°C
- cut the desired bands with scalpel and use them for in-gel Trypsin digestion
and mass spectroscopic analysis
10. b -galactosidase assay (Miller, 1972)
Z buffer: 100mM Na-phosphate pH 7.0, 10mM KCl, 1mM MgSO4,
100µg/ml chloramphenicol
1 M Na2CO3
ONPG: 4mg/ml in  0.1M phosphate buffer pH 7.0
SDS: 0.1% (w/v)
chloroform
day 1:
- prepare overnight cultures (3-4 ml) in minimal media M9 with necessary
supplements as required  eg  glycerol or other carbon source, casamino acids,
thiamine, antibiotics etc.
day 2:
- measure the OD600 of the overnight cultures diluted 1:5 or 1:10
- inoculate 10ml cultures in M9 media (containing 1mM IPTG; 0.5% (w/v)
salicin if required) to an OD600 of 0.15 and let them grow at 37°C till OD600 =
0.5
- when OD600  reaches 0.5 stop cultures on ice
- to perform enzyme assay prepare dilutions from the cooled cultures in ice cold
Z buffer
- add one drop of  0.1% (w/v) SDS and two drops of chloroform to the probes
on ice. Vortex the probes for at least 15 seconds and then immediately
pre-incubate them for 5 minutes at 28°C
- start the reaction by adding 0.2ml ONPG with a multipette and mix
- stop the reaction after 30 minutes by adding 0.5ml 1M Na2CO3 (or later, when
the color turns to a strong yellow, note exact time)
- centrifuge the probes for 5-10 minutes and then  measure the OD420
- calculate the enzyme activity in Miller units as
  Miller units  = OD420   x dilution factor x 1000
                           OD600   x time (minutes)
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11. ß-Glucosidase-assay (modified from (Schnetz and Rak, 1988)
Z buffer: 60 mM Na2HPO4, 40 mM NaH2PO4, 10 mM KCl, 1 mM
MgSO4, 100µg/ml chloramphenicol
1 M Na2CO3
PNPG: 8mg/ml in  0.1M phosphate buffer pH7.0
day 1:
- prepare overnight cultures (3-4 ml) in minimal media M9 with necessary
supplements as required  eg  glycerol or other carbon source, casamino acids,
thiamine, antibiotics etc.
day 2:
- measure the OD600 of the overnight cultures diluted 1:5 or 1:10
- inoculate 10ml cultures in M9 media (containing 1mM IPTG; 0.5% (w/v)
Salicin if required) to an OD600 of 0.15 and let them grow at 37°C till OD600 =
0.5
- when OD600 reach 0.5 stop cultures on ice
- to perform enzyme assay prepare dilutions from the cooled cultures in ice cold
Z buffer.
- pre-incubate them for 5 minutes at 37°C
- start the reaction by adding 0.2 ml PNPG to the  probes with a multipette and
mix
- stop the reaction after 30 minutes by adding 0.5ml 1M Na2CO3 (or earlier,
when the color turns to a strong yellow, note exact time). Centrifuge the
probes for 5-10 minutes and then  measure the OD410
- calculate the enzyme activity in as
  units  = OD410   x dilution factor x 1000
                      OD600   x time (minutes)
12. Transposition using the mini Tn10 (Tet) (l1323) (Kleckner et al., 1991)
- inoculate 4ml LB2Y with a colony of the strain to be mutagenised
- incubate overnight at 37°C -stationary (without shaking)
- next day-inoculate 9.5ml LB2Y with 0.5ml of the overnight culture and keep
stationary at 37°C for 2 hours
- shift it to 37°C shaker-1hour
- centrifuge at 3000rpm, 15 minutes. Resuspend in 1ml LB2Y containing 1mM
IPTG + 10ml 1M MgSO4
- make 1:10 dilution of the phage l1323 (5 x 1010 PFU/ml) using LB2Y
containing 1mM IPTG + MgSO4
- mix 200ml of phage dilution + 200ml of resuspended culture – keep at 37°C,
stationary for 15 minutes
- add 2ml LB2Y with 1mM IPTG –37°C shake for 90 minutes
- make 1:10 dilution (1:2 dilution if high colony count required) of this and
 - plate 100ml each on indicator tetracyclin plates.
- incubate at 41°C.
13. Transduction with Phage T4GT7 (Wilson et al., 1979; Plakidou et al., 1984)
      T4-Topagar 
      6g Bacto-Agar (Difco)
10g Bacto-Tryptone (Difco)
8g NaCl
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2g Tri-Natriumcitrate-Dihydrate
3g Glucose
ad 1l H2O
      T4GT7-plate lysate
- incubate 100µl overnight culture with T4GT7-lysate (10-2, 10-4, 10-6, 10-7, 10-8
ml) for 20 minutes at room temperature
- transfer bacteria-phage mixture in to 10ml reaction tubes containing 1ml LB2Y
- add 3ml T4-topagar, mix carefully by rolling the tube
- pore on to LB-plates, incubate plates at 37°C for 8-14h only
- take a plate which shows an almost confluent lysis
- pipette 1ml LB2Y on to plate, scratch top-agar off and transfer to 10ml glass
tubes
- extract at least twice with chloroform, use glass pistils to carefully mix top-agar
with chloroform
- determine phage titer, expected multiplicity of infection = 1011 phages/ml
     T4GT7-Transduction
- mix 100-200µl of a fresh overnight culture with T4GT7 lysate (eg 2µl, 0.5µl ,
0.1µl), incubate for  20 minutes at room temperature
- plate 1 x 100 µl, and 1 x 10 µl on to the respective plates for selection of the
transductants
- re-streak colonies several times to get rid of  contaminating T4GT7 phages
14. RNA preparation by hot phenol method modified from (Schnetz, 1995)
solution I: 50mM glucose
25mM Tris-HCl pH8.0
10mM ETDA
2mg/ml lysozyme  (add fresh)
TM: 10mM Tris-HCl pH7.5
10mM Mg2SO4
Mg-Saline: 0.85% NaCl
10 mM MgSO4
- grow 20ml culture to OD600 of 0.5 to 0.8, harvest in ice
- pellet cells by centrifugation (5000 rpm, 10 minutes)
- wash with Mg-Saline
- resuspend cell pellet in 200ml solution I with lysozyme and incubate for 5 to
10 minutes on ice
- transfer cell suspension to 2ml screw cap tube
- add 500ml phenol, 250ml 0.5 M Na-acetate pH5.2, and 20ml 6% SDS, make
sure tubes are tightly closed, vortex vigorously and incubate for 6 minutes at
80°C, mix every minute
- centrifuge (3-5 minutes, 12000rpm), transfer aqueous phase to fresh tube
- extract 2 to 3 times with chloroform/isoamylalcohol (24:1), transfer aqueous
phase to a new tube each time
- precipitate nucleic acids by the addition of 1/20 volume 3M NH4-Acetate
pH5.2 (or 3M Na-acetate) and 2 volumes ethanol (incubate for 5 minutes or
overnight at -20°C or on ice)
- centrifuge for 10 minutes, 12000 rpm
- wash with 80% ethanol and centrifuge for another 5 minutes, 12000rpm
- dry under vacuum
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- re-suspend nucleic acids in 200ml TM-buffer
- add 10U DNase (RNase free) and incubate for 1hour at 37°C
- extract once with phenol, followed by two chloroform:isoamylalcohol (24:1)
extractions
- precipitate RNA by adding 1/10 volume 3M NH4-acetate pH5.2 and 2.5
volume ethanol
- repeat DNase treatment once
- resuspend RNA pellets in 200ml DEPC treated H2O
- measure OD260 of an appropriate dilution
- the quality of the RNA preparation can be checked by loading 5mg of RNA (in
50% formamid, heated 65°C) on to a 4% acrylamide:bis (19:1), 7M Urea, 1x
TBE gel
- stain the gel with Ethidium-bromide 0.5mg/ml
15. RNA preparation for half life determination. modified from (Appleman et al.,
1998)
TM: 10 mM Tris-HCl  pH 7.5
10 mM Mg2SO4
Rifampicin stock: 50mg/ml in methanol (store in dark at -20°C)
(Control RNA for S1 experiment-start with 200ml LB2Y culture, OD~0.5, centrifuge
and proceed according to Hot Phenol method)
- grow LB2Y culture to OD600 of 0.5 (100ml culture for RNA half-life
determination experiment)
- optional: add rifampicin to final concentration of 100mg/ml
- transfer 5ml culture (optional: use different time points after Rifampicin
addition starting 2 minutes before Rifampicin addition = -2 minute sample) to
50ml tubes containing 750ml non buffered, water saturated phenol, 250ml 6%
SDS (and optional 200mg each of the control RNAs) preheated to 70°C.- mix
vigorously and keep at 70°C for at least 5 minutes
- centrifuge (3-5 minutes, 12000 rpm), transfer aqueous phase to an new tube
- extract 2 times more with chloroform/isoamylalcohol (24:1), transfer aqueous
phase to a new tube each time
- precipitate nucleic acids by the addition of 1/20 volume 3M NH4-Acetate, pH
5.2 (or 3M Na-acetate) and 2 volumes of ethanol (incubate for 5 minutes or
overnight at -20°C or on ice)
- centrifuge for 10 minutes, approx. 12000rpm
- wash with 80% ethanol and centrifuge for another 5 minutes, 12000rpm
- dry the pellet under vacuum
- re-suspend nucleic acids in 50ml TM-buffer
- add 2.5 units DNase (RNase free) and incubate for 1 hour at 37°C
- extract once with phenol, followed by two chloroform:isoamylalcohol (24:1)
extractions
- precipitate RNA by adding 1/10 volume 3M NH4-acetate pH 5.2 and 2.5
volumes of ethanol
- repeat DNase treatment once
- resuspend RNA pellets in 50ml DEPC treated H2O
- measure OD260 of an appropriate dilution
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- the quality of the RNA preparation can be checked by loading 5mg of RNA (in
50% formamid, heated 65°C) on to a 4% acrylamide:bis (19:1), 7M Urea, 1x
TBE gel
- stain the gel with Ethidium-bromide 0.5mg/ml
16. S1 nuclease assay
DNA Probe labeling (modified from T7 DNA polymerase sequencing kit protocol,
Amersham Pharmacia Biotech)
annealing buffer: 1M Tris-HCl (pH 7.5), 100mM MgCl2, 160mM DTT
labeling mix-dATP: 1.375mM each dCTP, dGTP and dTTP, 333.5mM NaCl
chase mix: 840mM each dATP, dCTP, dGTP and dTTP, 40mM Tris-HCl
(pH 7.5), 50mM NaCl
- denature 2mg plasmidic DNA (CsCl2 purified supercoiled DNA) by mixing
with 8ml 2M NaOH (total volume 40ml)
- vortex gently and incubate at room temperature for 10 minutes
- add 4ml 3M Sodium acetate pH 4.8, and 50ml 100% Ethanol
- quick freeze in liquid nitrogen and allow to slowly thaw at –20°C
- centrifuge, remove supernatant and air dry pellet
- add 10ml distilled water, 2ml primer (5pmol/ml), 2ml annealing buffer
- mix and incubate at 37°C for 30 minutes
- add 3ml labeling mix-dATP, 1ml a32p dATP(Amersham, specific activity
3000Ci/mMol ),  2ml diluted T7 DNA polymerase (1.6U/ml)
- mix and incubate at room temperature for 5 minutes
- add 19ml of this solution to 10.6ml of prewarmed chase mix
- incubate at 37°C for 1 hour
- stop reaction by extracting with phenol/chloroform/isoamyl alcohol (25:24:1)
- extract twice with chloroform/isoamyl alcohol (24:1)
- remove unincorporated radioactivity by loading on to a NAP-5 column
(Pharmacia) and elute in 1ml distilled water
- measure radioactive incorporation by measuring Cerenkov counts of 1ml
S1 reaction: modified from (Schnetz, 1995)
Na-TCA buffer: 3M Na-trichloroacetate, 50mM PIPES pH 7.0, 5mM EDTA
S1 digestion buffer: 250mM NaCl, 40mM Na-acetate pH 5.5, 1mM ZnCl2, 20mg/ml
denatured herring sperm DNA
- mix 200mg RNA with radiolabeled probe corresponding to half the labeling
reaction (approx. 300,000 cpm)
- quick freeze in liquid nitrogen and vacuum dry
- resuspend in 40ml Na-TCA buffer
- incubate at 65°C for 5 minutes and transfer to 45°C for at least 4 hours
- to 20ml of this reaction add 190ml digestion buffer containing 500U/ml S1
nuclease
- incubate at 37°C for 30 minutes
- stop by extracting with phenol/chloroform/isoamyl alcohol (25:24:1)
- extract twice with chlo roform/isoamyl alcohol (24:1)
- precipitate with 0.1 volume 3M NH4-acetate and 2.5 volume 100% ethanol
- wash with 80% ethanol
- resuspend in 9ml sequencing gel loading dye and load 3ml on the gel after
pre-heating at 80°C for 2 minutes
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- on the same gel, as molecular weight marker, run sequencing ladder prepared
according to T7 DNA polymerase sequencing kit protocol, Amersham
Pharmacia Biotech
17. DNA sequencing
Sequence analysis was done using the Big Dye terminator cycle sequencing kit (ABI
Prism) according to manufacturer's instructions and using an automated DNA
sequencer.
18. Genomic DNA sequencing
- prepare genomic DNA using the Qia-amp DNA mini kit (Qiagen)
- perform sequencing PCR  using 16ml Terminator ready dye mix (ABI Prism),
3mg genomic DNA, 10pmoles primer S156, distilled water to 40ml. (genomic
sequencing protocol from Big Dye protocol, ABI prism)
- purify the PCR reaction using centri-sep column (Princeton separations, Inc.)
- determine sequence using an automated DNA sequencer
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